Myocardial infarction

I9_MI

myocardial infarction: Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I21, I22 Hospital discharge: ICD-9 — 410 Hospital discharge: ICD-8 — 410 Cause of death: ICD-10 — I21, I22 Cause of death: ICD-9 — 410 Cause of death: ICD-8 — 410 2 out of 7 registries used, show all original rules.	36467
4. Check minimum number of events None	36467
5. Include endpoints None	36467
6. Filter based on genotype QC (FinnGen only)	36467

Control definitions (FinnGen only)

Control exclude: I9_ISCHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_MI
CONTROL_EXCLUDE	I9_ISCHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I21\|I22
HD_ICD_9	410
HD_ICD_8	410
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I21\|I22
COD_ICD_9	410
COD_ICD_8	410
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Myocardial infarction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	36467	10386	26081
Unadjusted period prevalence (%)	9.23	3.54	11.50
Median age at first event (years)	67.74	71.31	66.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13490: Matched controls
115849

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Angiography of the heart and coronary arteries

28.6

323.0

1605

544

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

323.0

1947

5685

AN4

Balloon angioplasty and drug eluding stent

+∞

323.0

1921

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4889.0

323.0

2404

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

323.0

7552

35184

I20.90

ICD-10 Finland

Angina pectoris, unspecified

293.8

323.0

781

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

323.0

344

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.5

323.0

1380

2862

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

11.8

323.0

792

608

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.7

323.0

1794

4623

AN3

Balloon angioplasty and metallic stent

+∞

323.0

1425

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.3

323.0

2192

4984

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4478.9

323.0

987

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

533.7

323.0

9204

464

I20.01

ICD-10 Finland

Unstable angina

2150.9

323.0

1192

I25.1

ICD-10 Finland

Atherosclerotic heart disease

633.2

323.0

9170

392

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

323.0

463

I50.1

ICD-10 Finland

Left ventricular failure

11.3

323.0

1076

884

WX892

NOMESCO Finland

Monitored bed care

4.1

323.0

1556

3605

XF402

NOMESCO Finland

ECG with work load test

4.1

323.0

2387

5730

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

3048

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

323.0

628

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

12.1

323.0

1125

866

I20.99

ICD-10 Finland

Angina pectoris, unspecified

132.2

323.0

1591

117

C10AA01

ATC

simvastatin; oral

3.3

323.0

8019

35478

XF400

NOMESCO Finland

ECG with 12 standard connections

3.9

323.0

3490

9426

201

Kela drug reimbursment

Chronic cardiac insufficiency

8.2

323.0

875

975

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

25.3

323.0

1753

680

I50.0

ICD-10 Finland

Congestive heart failure

8.4

323.0

1280

1430

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

162.9

323.0

1766

107

R07.4

ICD-10 Finland

Chest pain, unspecified

4.4

323.0

5671

16514

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

26.3

323.0

8216

6477

C09AA05

ATC

ramipril; oral

6.3

323.0

6538

15145

Coronary artery bypass surgery

+∞

323.0

375

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

105.6

323.0

678

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

983.6

323.0

550

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.1

323.0

2578

8184

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

2515

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

148.5

323.0

2227

154

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.9

323.0

3837

14080

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

651.1

323.0

441

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

542

WX872

NOMESCO Finland

Intensive care

8.0

323.0

1545

1848

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

+∞

323.0

928

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

1309

C03DA01

ATC

spironolactone; oral

3.8

323.0

1939

4936

C08CA01

ATC

amlodipine; oral

2.1

323.0

5592

29300

A02BC02

ATC

pantoprazole; systemic

2.1

323.0

9277

59282

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

1600

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.2

323.0

5250

12551

I20.00

ICD-10 Finland

Unstable angina

1005.8

323.0

979

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

106.3

323.0

760

C10AX09

ATC

ezetimibe; oral

8.7

323.0

3894

5138

C07AB02

ATC

metoprolol; systemic

3.1

323.0

3359

11042

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

683

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

1431

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

1555.1

323.0

665

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

6.0

323.0

4571

9053

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

323.0

1187

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.8

323.0

4481

7903

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

451.5

323.0

508

A10AE04

ATC

insulin glargine; parenteral

3.5

323.0

1788

4906

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

189.3

323.0

550

C01DA14

ATC

isosorbide mononitrate; oral

36.6

323.0

4189

1405

I25.2

ICD-10 Finland

Old myocardial infarction

3832.2

323.0

4220

Single vessel balloon catheter extension

+∞

323.0

709

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

70.2

323.0

10241

4974

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.4

323.0

4311

18987

B01AC24

ATC

ticagrelor; oral

13719.7

323.0

3574

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.5

323.0

1087

1537

A10BA02

ATC

metformin; oral

2.2

323.0

4425

20649

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3910.1

323.0

4037

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

323.0

9195

53275

I25

ICD-10 Finland

Chronic ischaemic heart disease

100.5

323.0

1753

172

C03CA01

ATC

furosemide; systemic

3.9

323.0

4884

14625

K76

ICPC

Ischaemic heart dis without angina

74.0

323.0

855

106

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

9.4

323.0

4325

5543

C07AB07

ATC

bisoprolol; oral

8.0

323.0

10375

33898

B01AC04

ATC

clopidogrel; oral

20.8

323.0

6181

4516

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

6.2

323.0

1749

2705

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

440.4

323.0

351

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

323.0

4391

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

323.0

3825

15613

AN2

Balloon angioplasty, including several vessels

+∞

323.0

1093

280

Kela drug reimbursment

Clopidogrel

1657.3

323.0

581

I50.9

ICD-10 Finland

Heart failure, unspecified

6.6

323.0

2446

3772

B01AA03

ATC

warfarin; systemic

2.7

323.0

2734

9884

C10AA07

ATC

rosuvastatin; oral

2.8

323.0

4744

18654

C10AA05

ATC

atorvastatin; oral

6.2

323.0

9234

29952

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1870.4

323.0

1435

AA1

Conventional CABG

+∞

323.0

514

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

77.0

323.0

459

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

6289.8

323.0

1341

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

8571.7

323.0

939

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

323.0

337

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

5511.1

323.0

4784

103

Kela drug reimbursment

Diabetes, insulin-treated

2.6

323.0

4597

19363

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

7903.3

323.0

1640

I20.09

ICD-10 Finland

Unstable angina

396.4

323.0

2187

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

172.0

323.0

3021

194

AN1

Coronary angiography

35.7

323.0

4991

1872

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1215.8

323.0

1942

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.4

321.5

1309

2776

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

317.6

322

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

1418.8

305.0

314

R06.0

ICD-10 Finland

Dyspnoea

2.3

304.4

3524

15303

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

1361.0

294.2

303

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.4

293.1

2990

12143

Z50.0

ICD-10 Finland

Cardiac rehabilitation

59.0

291.2

362

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

883.1

291.2

302

K74

ICPC

Ischaemic heart dis with angina

41.0

287.3

381

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

287.3

3284

14107

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

285.9

2654

10230

T90

ICPC

Diabetes non-insulin dependent

2.2

284.9

3818

17667

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

16.5

278.9

477

256

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.2

276.4

1644

4772

FL1AC

NOMESCO Finland

Left cardioangiography

21.1

273.8

430

180

205

Kela drug reimbursment

Chronic hypertension

2.1

273.3

4062

19600

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

2360.9

271.6

278

I20.91

ICD-10 Finland

Angina pectoris, unspecified

498.5

270.9

285

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.6

267.7

1033

2063

R4110

NOMESCO Finland

Physiotherapy

2.1

265.2

4148

20395

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

265.2

1336

3405

K84

ICPC

Heart disease other

8.6

261.6

614

641

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.9

257.3

1176

2755

AP1

Catheterization of the left side of the heart

19.3

256.6

415

190

A11

ICPC

Chest pain NOS

3.5

256.6

1350

3559

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

462.6

251.3

265

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

455.5

247.4

261

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

376.1

243.8

259

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

113.5

237.3

272

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

7.7

237.3

593

684

207

Kela drug reimbursment

Chronic arrhythmias

2.5

233.4

2110

7920

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

231.3

4136

21201

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

226.0

1160

2985

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

21.4

224.0

350

144

B01AC22

ATC

prasugrel; oral

261.7

220.3

238

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

4.8

217.5

789

1469

R07.3

ICD-10 Finland

Other chest pain

2.9

209.9

1459

4662

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

208.4

2900

13330

A10AE05

ATC

insulin detemir; parenteral

3.8

203.6

964

2313

C10AA03

ATC

pravastatin; oral

3.2

201.9

1201

3445

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.4

200.8

2082

8338

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.5

199.9

774

1540

C10AA04

ATC

fluvastatin; oral

2.9

199.5

1395

4466

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

1695.8

197.6

203

XF404

NOMESCO Finland

Ambulatory ECG

2.8

196.4

1459

4849

SPAT1262

SPAT

Handing over of treatment supplies

2.1

194.2

2774

12837

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.7

192.4

714

1359

A10AA02

ATC

5.6

191.2

603

955

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

1634.2

190.7

196

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

1616.6

188.7

194

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

5.2

188.7

636

1089

Catheterization and pressure measurement of the left side of the heart

23.9

188.2

284

104

AA1AD

NOMESCO Finland

CT of head and brain

1.9

187.9

3319

16671

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

181.1

184

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

275.0

177.4

191

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

175.2

178

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

172.2

175

I47.2

ICD-10 Finland

Ventricular tachycardia

7.5

170.3

434

514

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

8.0

168.0

408

448

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.3

167.5

1777

7141

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

165.8

1214

3980

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

+∞

165.3

168

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.7

164.1

799

1954

I20.0

ICD-10 Finland

Unstable angina

38.4

164.0

220

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

162.8

1266

4299

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

20.5

162.0

256

109

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

159.1

1248

4259

A10AA01

ATC

5.4

157.3

512

840

N02AX02

ATC

tramadol; systemic, rectal

1.7

157.2

5781

36154

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

155.4

158

I20

ICD-10 Finland

Angina pectoris

13.8

154.0

282

179

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.8

149.3

686

1594

A10BB12

ATC

glimepiride; oral

3.0

148.2

972

2961

ANB

Coronary thrombectomy

+∞

147.6

150

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

146.6

149

A10BK03

ATC

empagliflozin; oral

2.5

145.4

1247

4467

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

141.6

144

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

5.3

141.0

468

785

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.4

139.0

553

1124

SPAT1097

SPAT

Recording of ECG

2.0

138.8

2072

9609

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

138.3

3742

21243

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

23.8

138.0

208

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

7.2

137.6

359

440

I20.10

ICD-10 Finland

Angina angiospastic

1239.6

136.6

141

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

136.1

1221

4474

M04AA01

ATC

allopurinol; systemic

2.1

135.8

1719

7437

Multi-vessel balloon catheter extension

+∞

135.7

138

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

15.5

134.1

234

132

111

Conventional CABG

+∞

133.8

136

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

23.7

133.1

201

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.7

131.8

483

903

N02BE01

ATC

paracetamol; systemic, rectal

1.8

131.7

11299

86332

C01BD01

ATC

amiodarone; systemic

4.5

131.7

510

1009

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

4.1

131.5

554

1189

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.1

130.7

786

2249

C09AA02

ATC

enalapril; systemic

1.8

130.6

2615

13464

I21

ICD-10 Finland

Acute myocardial infarction

177.2

129.5

143

TK800

NOMESCO Finland

Hemodialysis

4.9

129.3

457

822

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

391.5

128.3

136

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.8

127.4

598

1413

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

125.4

2271

11272

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

125.1

1233

4735

I20.9

ICD-10 Finland

Angina pectoris, unspecified

19.2

124.8

201

FXZ00

NOMESCO Finland

Off-pump cardiac operation

52.1

123.4

156

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

+∞

122.9

125

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

122.6

3597

20754

H3603, E103

ICD-10 Finland

9.7

121.6

264

239

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

1082.4

120.9

125

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

120.0

122

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

119.5

584

1427

B01AF02

ATC

apixaban; oral

2.2

117.4

1304

5299

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

116.8

781

2398

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

116.4

1395

5868

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.0

116.3

406

720

AA2

Off pump CABG sternotomy

+∞

115.0

117

I50

ICD-10 Finland

Heart failure

5.3

114.8

380

635

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

12.2

113.8

219

156

A10BH01

ATC

sitagliptin; oral

2.1

112.3

1375

5832

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.0

112.3

386

673

C01AA05

ATC

digoxin; systemic

2.9

111.6

735

2234

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.9

111.5

495

1113

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

7.6

110.4

277

320

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

986.3

110.1

114

ANE

Coronary internal ultrasound (IVUS)

977.5

109.1

113

C08DB01

ATC

diltiazem; oral

3.3

108.4

601

1620

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

107.8

424

851

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

487.8

107.4

113

T89

ICPC

Diabetes insulin dependent

3.3

105.9

577

1534

K75

ICPC

Acute myocardial infarction

96.9

105.9

123

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

104.7

1432

6353

I35.0

ICD-10 Finland

Aortic (valve) stenosis

3.1

104.4

628

1794

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

104.2

106

SPAT1254

SPAT

Administration of medicine

1.9

104.1

1656

7795

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.4

104.0

411

829

K01

ICPC

Heart pain

8.0

103.5

251

275

C09DX04

ATC

valsartan and sacubitril; oral

12.3

103.3

198

140

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

124.5

101.4

115

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.2

101.2

225

213

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

100.8

1717

8276

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

11.2

100.3

201

156

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

100.3

855

3029

R53

ICD-10 Finland

Malaise and fatigue

1.8

98.7

2129

11107

A10BB01

ATC

glibenclamide; oral

4.2

98.3

402

838

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

97.7

819

2876

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

+∞

97.3

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

11.8

97.3

190

140

R03BB04

ATC

tiotropium bromide; inhalant

2.1

96.9

1196

5073

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.1

96.9

573

1615

R02

ICPC

Shortness of breath/dyspnoea

2.0

96.1

1424

6510

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

95.9

1663

8057

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

12.4

94.8

181

127

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

94.8

3461

20866

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

9.6

94.7

205

185

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

+∞

93.4

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

93.4

H02AB06

ATC

prednisolone; systemic

1.5

93.1

5654

38140

ZX120

NOMESCO Finland

Intravenous

2.1

93.1

1232

5380

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.4

92.9

361

716

PE1AT

NOMESCO Finland

Femoral artery PTA

8.0

92.8

224

244

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.3

92.2

498

1314

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.2

92.0

265

373

J01FF01

ATC

clindamycin; systemic

1.6

91.7

3448

20901

FN2EA

NOMESCO Finland

Coronary rotablation

+∞

91.4

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

91.3

1338

6082

R07.2

ICD-10 Finland

Precordial pain

4.8

91.0

328

602

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

+∞

90.4

5315

FHL

Bypass surgery using a mammary artery

+∞

90.4

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

6.9

90.4

240

302

C08CA02

ATC

felodipine; oral

2.1

89.9

1183

5147

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.5

89.5

250

338

I20.8

ICD-10 Finland

Other forms of angina pectoris

43.7

89.1

116

NHQ40

NOMESCO Finland

Amputation of toe

5.3

88.6

289

475

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

5.3

88.4

291

483

C08CA13

ATC

lercanidipine; oral

1.8

88.3

1763

8943

A10BH05

ATC

linagliptin; oral

2.8

87.5

625

1997

M10.9

ICD-10 Finland

Gout, unspecified

2.3

86.8

866

3324

B01AC07

ATC

dipyridamole; systemic

3.9

86.7

383

857

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

86.6

880

3408

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.8

86.1

262

396

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

7.1

86.1

224

274

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.8

85.7

393

909

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

5.1

85.6

289

494

A28

ICPC

Limited function/disability NOS

1.8

85.4

1599

7932

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.7

84.3

306

566

N02AA05

ATC

oxycodone; systemic

1.8

83.8

1747

8969

SPAT1263

SPAT

Sampling

1.5

83.7

4880

32416

C08CA07

ATC

nisoldipine; oral

14.4

82.9

148

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

+∞

82.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

82.5

1375

6546

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.4

81.8

261

418

S97

ICPC

Chronic ulcer skin

2.5

81.8

724

2613

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

+∞

81.6

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.5

81.4

310

603

A11CC03

ATC

alfacalcidol; systemic

3.9

81.3

360

807

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

80.3

506

1490

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

80.2

758

2828

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.5

80.1

302

581

C02AC05

ATC

moxonidine; oral

2.5

79.6

659

2293

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.8

79.1

180

178

WX890

NOMESCO Finland

Intesive care monitoring

10.7

79.0

161

130

R55

ICD-10 Finland

Syncope and collapse

1.9

78.5

1198

5514

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

13.6

78.3

143

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

78.0

1303

6199

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

77.7

1109

4976

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.3

77.1

417

1101

A46

ICD-10 Finland

Erysipelas

1.7

77.1

1754

9233

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

77.1

974

4158

H3603, E113

ICD-10 Finland

7.4

76.2

193

227

I42.8

ICD-10 Finland

Other cardiomyopathies

11.5

76.1

150

113

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

75.4

795

3129

N03AX16

ATC

pregabalin; oral

1.5

75.0

2928

17756

K78

ICPC

Atrial fibrillation/flutter

2.2

74.6

851

3471

H3601, E113

ICD-10 Finland

4.9

74.4

262

470

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.0

74.3

457

1322

I20.19

ICD-10 Finland

Angina angiospastic

339.3

74.2

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

74.2

684

2519

A12BA01

ATC

potassium chloride; oral

3.0

74.2

463

1354

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

41.9

74.1

SPAT1104

SPAT

Monitoring of emergency patient

2.2

73.7

844

3448

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.8

73.3

221

331

R2110

NOMESCO Finland

Giving the first information

2.3

73.2

724

2762

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.8

72.9

221

333

K77

ICPC

Heart failure

5.6

72.0

225

352

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.6

71.9

224

349

A12AA04

ATC

calcium carbonate; oral

4.8

71.7

256

466

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

71.5

1930

10653

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

71.4

1608

8422

B04AB02

ATC

6.2

71.0

203

284

PD5AD

NOMESCO Finland

CT of aorta

4.9

70.7

245

432

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

70.5

3146

19602

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

70.3

387

1036

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

70.2

4544

30499

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.5

69.9

357

902

K22

ICPC

Risk factor cardiovascular disease

2.3

69.7

711

2753

C07AG02

ATC

carvedilol; oral

2.2

69.6

737

2902

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

69.6

4597

30960

I44.2

ICD-10 Finland

Atrioventricular block, complete

4.2

69.0

282

588

FXG00

NOMESCO Finland

Insertion and use of IABP

50.1

68.7

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.1

68.1

285

608

I21.30

ICD-10 Finland

Acute transmural myocardial infarction with unspecified location no detected stenosis of coronary artery

611.7

68.0

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

9.2

67.7

150

142

C09CA01

ATC

losartan; oral

1.5

67.5

3109

19477

C10AX13

ATC

evolocumab; parenteral

70.0

67.3

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

67.1

321

770

WX720

NOMESCO Finland

Own respiration

2.7

66.6

487

1574

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

66.1

610

2246

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

66.0

444

1363

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

65.9

846

3626

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

4.6

65.7

243

459

SPAT1301

SPAT

No procedures

1.4

65.7

3557

23004

I51.4

ICD-10 Finland

Myocarditis, unspecified

10.0

65.3

138

120

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.1

64.9

809

3426

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

+∞

64.8

L28

ICPC

Limited function/disability (L)

1.6

64.3

1718

9431

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.7

64.3

471

1526

K92

ICPC

Atherosclerosis/periph vascular dis

5.9

64.2

190

278

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.4

64.1

179

243

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

576.9

64.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

64.0

5688

40174

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

+∞

63.9

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.8

63.9

226

408

J01MA12

ATC

levofloxacin; systemic

1.6

63.5

2191

12835

R04.0

ICD-10 Finland

Epistaxis

2.1

63.4

826

3563

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

9.2

63.4

140

132

GD1LA

NOMESCO Finland

4.9

63.1

220

391

C02EA02

ATC

2.7

62.9

462

1499

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.2

62.8

362

1000

A10AE06

ATC

insulin degludec; parenteral

2.9

62.1

399

1190

C09AA04

ATC

perindopril; oral

2.2

61.6

662

2623

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.6

61.4

229

437

C08CA05

ATC

nifedipine; systemic

2.2

61.3

672

2689

TFN04

NOMESCO Finland

48.1

61.2

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

61.2

851

3768

N18.0

ICD-10 Finland

End-stage renal disease

5.5

60.9

192

304

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.9

60.9

212

376

TFN40

NOMESCO Finland

Catheterisation of heart with balloon widening of coronary vessels

+∞

60.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

60.9

558

2047

N19

ICD-10 Finland

Unspecified kidney failure

3.1

60.7

364

1036

I49.5

ICD-10 Finland

Sick sinus syndrome

2.9

60.5

394

1185

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

60.5

3689

24325

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.5

60.3

190

301

PEN23

NOMESCO Finland

Plastic repair of femoral artery

7.4

60.1

152

179

C10AA02

ATC

lovastatin; oral

2.7

60.1

437

1408

1CX08

NOMESCO Finland

14.2

59.9

107

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.8

59.6

266

602

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

58.9

714

2986

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

6.8

58.7

157

201

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.4

58.6

136

140

K02

ICPC

Pressure/tightness of heart

3.4

58.2

308

801

R42

ICD-10 Finland

Dizziness and giddiness

1.5

58.0

2339

14166

H36.01

ICD-10 Finland

Diabetic maculopathy

4.9

57.9

203

363

WX882

NOMESCO Finland

High dependency care

2.9

57.8

374

1120

C03AA03

ATC

hydrochlorothiazide; oral

1.8

56.9

1117

5585

B01AB05

ATC

enoxaparin; parenteral

1.4

56.9

3720

24783

PD3AT

NOMESCO Finland

Pelvic artery PTA

9.8

56.8

121

107

H3600, E103

ICD-10 Finland

5.3

56.4

182

297

J01DB01

ATC

cefalexin; oral

1.4

56.3

10225

80227

A10BK01

ATC

dapagliflozin; oral

2.2

56.1

645

2633

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

55.4

714

3063

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.1

55.2

330

938

V03AE01

ATC

polystyrene sulfonate; oral

4.8

55.1

194

349

H3600, E113

ICD-10 Finland

4.7

54.7

197

363

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

54.6

1315

6990

WX722

NOMESCO Finland

PEEP

2.1

54.3

660

2762

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

+∞

54.0

A02BC01

ATC

omeprazole; systemic

1.4

53.7

3068

19899

WX730

NOMESCO Finland

Conventional respirator

3.7

53.6

246

571

XPX08

NOMESCO Finland

Intraoperative flow measurement

7.6

53.6

132

150

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.7

53.4

192

353

R03AC02

ATC

salbutamol; inhalant

1.3

53.3

5790

41771

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.3

53.2

543

2100

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

53.1

1056

5298

C09CA03

ATC

valsartan; oral

1.7

53.0

1130

5795

B03XA02

ATC

darbepoetin alfa; parenteral

3.6

52.8

259

635

SPAT1310

SPAT

Counselling related to known health issue

1.4

52.8

3628

24309

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

52.8

1577

8880

H3601, E103

ICD-10 Finland

5.5

52.6

164

257

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

10.2

52.5

109

H04AA01

ATC

glucagon; nasal, parenteral

3.6

52.5

255

620

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

52.3

1322

7119

K29

ICPC

Cardiovascular sympt/complt other

2.3

52.2

512

1943

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.1

52.2

174

295

5314

FHL

Bypass surgery for four or more vessels

+∞

52.1

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

4.8

52.0

185

337

315

Kela drug reimbursment

Clopidogrel

6.2

52.0

148

207

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

10.2

51.8

108

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

9.3

51.7

113

105

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

51.6

853

4022

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.7

51.6

367

1167

CKC15

NOMESCO Finland

Panretinal photocoagulation

6.4

51.6

143

193

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.3

51.5

166

271

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

51.3

351

1091

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.6

51.3

140

185

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

+∞

51.1

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

+∞

51.1

R11

ICD-10 Finland

Nausea and vomiting

1.9

51.0

775

3544

A10BJ06

ATC

semaglutide; parenteral

2.4

50.8

465

1704

A06AD11

ATC

lactulose; oral

1.6

50.7

1362

7455

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

50.6

2479

15580

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.9

50.5

327

980

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

50.3

525

2051

M79.6

ICD-10 Finland

Pain in limb

1.4

50.3

4025

27613

C07AB03

ATC

atenolol; systemic

2.1

50.3

617

2592

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

7.8

50.2

122

136

41099

ICD-8 Finland

Acute myocardial infarction, Without mention of hypertensive disease

+∞

50.1

287

Kela drug reimbursment

Ticagrelor 60 mg

+∞

50.1

I21.3

ICD-10 Finland

Acute transmural myocardial infarction of unspecified site

233.5

50.0

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.5

49.9

250

624

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.6

49.8

376

1240

SPAT1252

SPAT

Overall medication plan or its review

1.9

49.7

750

3421

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

4.9

49.5

173

309

137

Kela drug reimbursment

Uraemia requiring dialysis

5.5

49.3

154

242

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.4

49.0

250

633

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

48.7

621

2650

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

5.9

48.6

143

209

A04

ICPC

Weakness/tiredness general

1.7

48.4

1158

6138

E87.5

ICD-10 Finland

Hyperkalaemia

4.1

48.3

200

424

UJF32

NOMESCO Finland

Coloscopy

1.4

48.3

2985

19578

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.8

48.2

326

1004

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

48.1

1705

9992

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

47.8

1673

9771

K99

ICPC

Cardiovascular disease other

2.9

47.6

314

952

XF640

NOMESCO Finland

2.7

47.6

352

1148

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.7

47.4

172

320

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

47.3

572

2386

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.1

47.2

197

421

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

46.7

650

2874

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

46.4

1835

11011

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.2

46.3

530

2160

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

46.2

1282

7068

FNA96

NOMESCO Finland

Other connection to coronary artery from internal mammary artery

+∞

46.2

5253

FHL

Cardiac lung machine

16.6

46.0

N03AX12

ATC

gabapentin; oral

1.5

45.9

1741

10347

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

45.8

508

2042

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

45.6

1449

8266

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

8.2

45.6

107

113

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

45.5

503

2017

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

10.4

45.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

45.3

387

1369

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.4

45.3

173

340

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

45.2

777

3710

I21.42

ICD-10 Finland

Acute subendocardial infarction thrombus in coronary artery

+∞

45.2

SPAT1255

SPAT

Intravenous administration of medicine

1.9

44.9

751

3553

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

44.7

2338

14841

R50.9

ICD-10 Finland

Fever, unspecified

1.6

44.6

1411

8041

N05CF01

ATC

zopiclone; oral

1.3

44.4

3601

24646

K92.1

ICD-10 Finland

Melaena

2.1

44.3

539

2255

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

44.2

808

3936

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

5.9

44.0

129

188

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.6

43.9

214

523

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

43.9

1809

10942

L04AA06

ATC

mycophenolic acid; systemic

3.1

43.2

258

732

I21.08

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

43.2

M01AH05

ATC

etoricoxib; oral

0.8

43.0

5889

57852

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.8

42.7

286

877

TK810

NOMESCO Finland

Hemofiltration

5.8

42.7

128

192

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

42.6

2991

19971

Z49.2

ICD-10 Finland

Other dialysis

5.7

42.6

129

196

I20.08

ICD-10 Finland

Unstable angina

386.0

42.6

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.9

42.4

125

184

K28

ICPC

Limited function/disability (K)

3.1

42.3

244

678

WW502

NOMESCO Finland

Autotransfusion

7.7

42.2

103

116

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.4

42.1

116

156

AS7

Arrhythmia pacemaker insertion VVI (R) S

17.5

42.1

C10AB02

ATC

bezafibrate; oral

4.2

42.1

168

345

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

6.9

42.0

110

138

N07BA03

ATC

varenicline; oral

1.9

42.0

619

2798

M48.0

ICD-10 Finland

Spinal stenosis

1.5

41.9

1393

8022

127

Kela drug reimbursment

Transplant complication

3.2

41.8

236

645

J01DA01

ATC

[U] cefalexin; systemic

1.3

41.7

7239

54949

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

6.7

41.1

110

142

EBA00

NOMESCO Finland

Extraction of tooth

1.3

41.1

3644

25214

A02BA02

ATC

ranitidine; systemic

1.4

41.1

2157

13672

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

41.0

1418

8241

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

6.7

40.9

109

140

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

6.4

40.8

113

153

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

40.8

439

1740

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

12.3

40.8

G47.3

ICD-10 Finland

Sleep apnoea

1.4

40.6

2718

17983

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

40.5

3225

21941

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.0

40.5

136

234

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

40.4

3513

36618

C09BA02

ATC

enalapril and diuretics; systemic

1.7

40.1

975

5181

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

40.0

889

4604

CKC12

NOMESCO Finland

Photocoagulation of retina

2.0

39.9

549

2415

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3.4

39.8

205

524

E86

ICD-10 Finland

Volume depletion

3.1

39.8

235

664

C02DE04

ATC

3.6

39.8

189

453

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

39.8

220

594

C09AA01

ATC

captopril; oral

3.7

39.7

184

432

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

3.7

39.7

183

428

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5656

24469

1.85

308.19

3.8

3.4

mmol/l

0.8

1.22

5268

22697

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4969

16880

2.39

307.65

9.1

6.9

kpa

5.0

5.1

12.91

4716

16144

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12925

55569

2.40

307.65

6.5

3.1

ng/l

227.5

33.7

7.01

10718

40942

(3023368) Bacteria identified in Blood by Culture

9274

42885

1.88

307.65

5.3

4.3

—

(3003396) Base excess in Arterial blood by calculation

4949

16899

2.38

307.65

9.2

6.9

mmol/l

0.9

1.0

2.30

3865

13469

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5141

11128

3.92

307.65

3.1

2.0

ug/l

12.0

5.9

25.68

4576

9362

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4109

11878

2.78

307.65

3.9

2.5

ng/l

329.9

171.9

50.57

3837

10749

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5895

24671

1.94

307.65

2.0

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4969

16872

2.39

307.65

9.1

6.9

kpa

11.5

12.4

27.57

4716

16129

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5464

20714

2.15

307.65

3.4

2.3

g/l

2.3

1.37

5098

18997

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6268

22119

2.38

307.65

2.6

1.9

31.5

29.6

65.61

6088

21456

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9758

45398

1.89

307.65

2.6

2.1

u/l

232.7

219.6

0.76

9161

42426

(3032080) INR in Blood by Coagulation assay

13643

62497

2.26

307.65

12.5

8.4

inr

1.3

12.52

3599

16800

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7749

35539

1.82

307.65

2.6

2.2

mg/l

3.2

3.0

9.10

6685

29794

(3022948) Iron [Moles/volume] in Serum or Plasma

5742

22356

2.10

307.65

3.4

2.4

umol/l

11.1

13.0

69.01

5361

20525

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8350

27333

2.80

307.65

7.1

2.9

ng/l

1671.6

190.3

57.74

7796

22083

(3019060) Gas panel - Arterial blood

2999

9325

2.49

307.65

5.9

4.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

4033

13200

2.42

307.65

10.5

6.5

mmol/l

11.7

10.1

31.23

3820

12494

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11785

42741

2.87

307.65

4.2

2.6

ng/l

2537.6

1190.0

80.84

10766

36098

(3016502) Oxygen saturation in Arterial blood

4560

15008

2.45

307.65

9.5

7.3

95.2

95.6

3.97

4391

14494

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1998

5047

3.00

307.65

3.5

2.7

u/ml

0.3

0.4

1.55

1252

2716

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2754

8688

2.43

307.65

8.9

6.7

mmol/l

24.3

24.7

5.99

2597

8088

(3012544) pH of Venous blood

3884

14313

2.12

307.65

5.3

3.5

7.4

0.70

(3013826) Glucose [Moles/volume] in Serum or Plasma

16273

87751

1.96

307.65

7.4

4.5

mmol/l

7.3

6.8

131.86

15644

82332

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5263

19434

2.20

307.65

3.5

2.4

19.8

23.1

55.56

4537

16477

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4119

13804

2.37

307.65

10.1

7.7

g/l

120.2

121.7

4.14

3985

13326

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3703

13891

2.07

304.49

5.3

3.5

kpa

5.8

0.15

3584

13527

(3002032) Base excess in Venous blood by calculation

3698

13885

2.07

303.23

5.3

3.5

mmol/l

1.7

1.9

2.02

3022

11390

(3014576) Chloride [Moles/volume] in Serum or Plasma

4718

19324

1.93

303.21

9.5

6.8

mmol/l

104.4

104.3

0.31

4573

18936

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4179

16661

1.96

289.07

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4172

16760

1.95

281.57

1.9

1.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2728

9386

2.22

277.39

11.8

8.8

0.7

0.04

2707

9332

(3000991) Gas panel - Venous blood

3400

12777

2.05

276.11

11.4

7.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4899

20953

1.84

272.23

28.9

24.7

inr

1.5

1.4

5.47

642

2947

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6241

28732

1.75

271.13

2.3

1.6

mg/l

1.5

1.4

0.17

4957

22331

(3014007) Fractional oxyhemoglobin in Arterial blood

2714

9476

2.19

265.62

11.9

8.8

93.6

93.9

1.40

2700

9448

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2704

9434

2.19

265.10

11.5

8.7

1.4

1.33

2684

9375

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4650

19751

1.85

263.03

8.4

5.4

mmol/l

1.1

1.0

44.84

4353

18250

(3020682) Albumin/Creatinine [Ratio] in Urine

9579

49780

1.62

260.82

4.4

3.9

mg/mmol

16.5

8.0

28.52

6400

31157

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2412

8096

2.26

259.26

12.6

9.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3497

13572

1.99

258.57

9.5

6.5

mmol/l

1.4

1.3

3.63

3345

13096

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13675

77655

1.59

254.62

6.6

6.7

umol/l

12.2

12.0

1.06

13058

73590

(3012516) Albumin [Mass/volume] in Urine

9143

47177

1.62

254.50

3.5

3.2

mg/l

333.9

423.8

1.30

6312

29488

(3004451) EKG impression Narrative

472

537

6.41

245.79

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

3002

11346

2.02

237.49

4.2

2.8

kpa

4.7

4.6

1.48

2887

10994

(3009508) Creatinine [Moles/volume] in Urine

9156

48298

1.57

224.34

3.5

3.2

mmol/l

7.2

7.7

29.49

7588

39898

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1726

5403

2.39

215.92

3.0

2.1

ug/l

633.0

564.3

0.35

1666

5068

(3027945) Reticulocytes/100 erythrocytes in Blood

4065

17701

1.78

206.43

2.4

2.5

1.9

1.7

14.16

3601

15486

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9765

52958

1.53

206.31

3.7

2.7

ug/l

161.9

172.6

2.28

8987

47893

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2294

8359

2.07

198.29

11.9

8.7

mmol/l

24.1

24.4

3.95

2106

7827

(3018405) Lactate [Moles/volume] in Arterial blood

1546

4840

2.38

192.75

5.2

4.0

mmol/l

1.5

1.4

1.61

1514

4764

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2390

9020

2.00

187.23

9.9

6.5

mmol/l

24.5

24.9

5.55

2370

8936

(3004119) Hemoglobin [Mass/volume] in Venous blood

2356

8974

1.98

179.46

4.6

2.9

g/l

123.4

130.0

33.36

2283

8785

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1986

7107

2.09

179.26

5.8

3.8

mmol/l

23.9

24.2

4.59

1764

6406

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1736

5924

2.19

176.65

6.2

4.7

1.8

1.6

2.41

1632

5586

(3007930) Methemoglobin/Hemoglobin.total in Blood

1688

5819

2.16

167.21

6.4

4.7

0.9

0.64

1588

5487

(3043409) Potassium [Moles/volume] in Arterial blood

1324

4141

2.37

164.83

5.7

4.2

mmol/l

4.0

3.9

7.58

1227

3893

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1931

7072

2.04

163.32

1.6

1.7

g/l

1.7

1.6

5.49

1684

5997

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12970

76931

1.44

159.23

10.2

6.5

mmol/l

1.2

118.86

11134

64288

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2181

8432

1.94

158.21

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1764

6351

2.07

155.92

2.1

1.9

ug/l

2.0

2.3

0.47

1573

5532

(3023520) Reticulocytes [#/volume] in Blood

3087

13404

1.75

154.33

2.5

2.7

e9/l

72.6

68.0

8.60

2357

10157

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11959

70220

1.43

152.28

9.4

5.8

mmol/l

1.2

112.91

11028

62861

(3020891) Body temperature

1609

5674

2.11

149.97

6.3

4.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

20903

159508

0.62

138.51

37.7

21.9

g/l

131.8

136.3

265.47

20624

156693

(3026361) Erythrocytes [#/volume] in Blood

20901

159478

0.62

137.89

37.4

21.7

e12/l

4.4

4.5

185.74

20301

153845

(3024731) MCV [Entitic volume]

20901

159472

0.62

137.68

37.3

21.7

91.8

91.5

18.16

20617

156627

(3010813) Leukocytes [#/volume] in Blood

20906

159497

0.62

137.53

37.4

21.8

e9/l

7.5

6.7

235.02

20313

153885

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3894

18492

1.61

137.20

4.2

4.5

u/l

252.3

242.7

2.66

3672

17425

(3035941) MCH [Entitic mass]

20900

159445

0.62

136.96

37.2

21.6

30.4

30.5

6.58

20616

156609

(3047181) Lactate [Moles/volume] in Blood

1286

4303

2.21

136.38

7.6

5.6

mmol/l

1.4

1.3

3.01

1150

3803

(3007461) Platelets [#/volume] in Blood

20900

159392

0.62

135.16

37.4

21.7

e9/l

237.4

244.0

36.78

20385

154370

(3027273) Bicarbonate [Moles/volume] in Venous blood

1871

7228

1.93

135.14

4.7

3.1

mmol/l

25.0

25.3

2.24

1816

7035

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2547

10897

1.76

132.72

1.8

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2363

9912

1.79

131.63

4.7

3.5

kpa

5.1

5.2

1.47

2206

9107

(3026008) Bacteria identified in Urine by Culture

7982

44380

1.43

131.16

3.8

3.2

—

(3039000) Anion gap in Blood

997

3050

2.40

129.80

8.2

6.5

mmol/l

11.6

11.1

4.22

906

2760

(3018572) Chloride [Moles/volume] in Blood

997

3050

2.40

129.80

8.2

6.5

mmol/l

105.1

104.8

0.81

906

2760

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1805

6984

1.92

129.58

3.6

2.6

1.2

0.26

1795

6954

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8277

46404

1.42

129.44

2.9

2.6

u/l

57.1

59.6

3.05

7682

42429

(3009343) pH of Capillary blood

2331

9792

1.78

129.09

4.7

3.4

7.4

0.68

357

1231

(3024561) Albumin [Mass/volume] in Serum or Plasma

11273

66691

1.39

128.81

6.0

4.8

g/l

33.7

35.0

95.47

10495

61439

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11451

68040

1.39

126.64

4.9

4.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8002

44809

1.42

124.79

3.3

u/l

40.9

35.1

2.99

7542

42196

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2252

9462

1.78

124.40

4.7

3.4

mmol/l

1.8

0.18

1671

7130

(3007853) Bacteria identified in Skin by Aerobe culture

3566

16967

1.59

123.35

2.2

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1754

6844

1.90

122.56

3.6

2.6

0.7

0.01

1694

6551

(3028626) Oxygen [Partial pressure] in Capillary blood

993

3134

2.33

120.52

3.5

2.8

kpa

7.9

8.0

2.76

927

2888

(3024928) Oxygen saturation in Venous blood

974

3048

2.35

120.50

4.2

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1115

3731

2.20

117.93

3.9

2.9

mmol/l

24.7

24.8

0.56

986

3252

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2245

9643

1.74

114.46

1.8

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1696

6699

1.88

113.91

5.4

3.6

48.6

48.0

0.44

1678

6625

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

203

216

6.79

112.14

8.7

8.1

—

(3033658) Prothrombin time (PT) actual/Normal

7007

38921

1.41

111.43

5.3

4.0

82.7

88.1

60.07

6839

38052

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1218

4320

2.08

111.05

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5632

30164

1.44

109.34

1.9

1.8

nmol/l

1163.8

1140.5

1.01

4349

22143

(3021901) Oxygen saturation in Capillary blood

853

2689

2.32

103.65

3.5

2.7

—

(3000850) Epithelial cells [#/volume] in Urine

5946

32561

1.41

100.55

3.2

2.6

e6/l

5.0

4.7

0.84

5283

28355

(3044640) Blood type and Crossmatch panel - Blood

8237

47646

1.36

99.69

3.1

2.5

—

(3010421) pH of Blood

1075

3794

2.08

99.12

5.4

3.7

7.4

2.42

940

3227

(3002582) Erythrocytes [#/volume] in Urine

8186

47437

1.36

97.29

4.0

3.3

e6/l

96.8

93.5

0.08

6553

36241

(3026493) Urate [Moles/volume] in Serum or Plasma

7144

40529

1.37

97.11

3.3

2.7

umol/l

4675.0

5224.9

0.48

6142

34718

(3042936) Bacteria identified in Isolate by Culture

4195

21722

1.46

95.44

2.5

2.0

—

(3027315) Oxygen [Partial pressure] in Blood

964

3322

2.13

94.49

5.5

3.8

kpa

8.4

8.5

0.77

943

3242

(3012501) Base excess in Blood by calculation

958

3306

2.12

93.55

5.5

3.8

mmol/l

2.5

2.7

0.83

663

2280

(3013290) Carbon dioxide [Partial pressure] in Blood

958

3307

2.12

93.48

5.5

3.8

kpa

5.0

0.68

937

3228

(3030467) Casts [#/volume] in Urine by Automated count

7563

43504

1.36

93.29

3.9

3.2

e6/l

0.6

0.4

3.84

5948

32512

(1616796) Gas panel - Central venous blood

951

3278

2.13

93.14

4.9

3.4

—

(40767503) Oxygen content in Capillary blood by calculation

922

3148

2.14

92.49

3.2

2.5

15.7

16.4

4.88

486

1676

(3038071) Oxygen [Partial pressure] in Mixed venous blood

171

187

6.60

92.31

8.8

8.2

—

(3006315) Basophils [#/volume] in Blood

11627

71486

1.32

89.59

6.3

5.9

e9/l

0.0

2.53

9926

60762

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1060

3870

2.01

89.08

2.9

2.3

g/l

3.7

3.6

0.22

1021

3686

(3001604) Monocytes [#/volume] in Blood

11544

71060

1.31

87.26

6.3

5.8

e9/l

0.7

0.6

76.96

9850

60368

(3006576) Bicarbonate [Moles/volume] in Blood

235

376

4.52

86.18

7.2

4.9

mmol/l

25.3

25.0

0.40

203

347

(3013115) Eosinophils [#/volume] in Blood

11889

73648

1.30

84.78

6.5

6.1

e9/l

0.2

13.87

10297

63384

(36304419) Bacteria [Presence] in Urine

7230

41796

1.34

84.24

3.8

3.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

862

2980

2.11

83.71

3.1

nmol/l

0.8

1.49

651

2298

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1004

3680

2.00

83.39

2.5

2.3

ug/min

151.4

97.2

3.17

618

2111

(3019198) Lymphocytes [#/volume] in Blood

11765

72891

1.30

83.12

6.4

5.9

e9/l

1.8

1.9

2.00

10178

62963

(3018095) Leukocytes [#/volume] in Urine

9024

53948

1.32

82.86

4.5

3.8

e6/l

116.3

102.8

0.56

6900

38686

(3026782) Osmolality of Urine

5512

30618

1.38

82.78

3.4

2.7

mosm/kgh2o

535.0

561.8

16.93

4799

25945

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3270

16607

1.48

80.74

2.7

2.9

umol/l

8.6

10.1

3.93

2870

14627

(3028271) Lactate [Moles/volume] in Capillary blood

710

2307

2.24

80.31

2.3

1.8

mmol/l

1.8

0.01

694

2254

(3022806) Fractional oxyhemoglobin in Capillary blood

598

1804

2.41

80.01

2.1

1.8

88.9

89.4

0.96

586

1782

(3022096) Basophils/100 leukocytes in Blood

10647

65315

1.30

79.76

6.6

6.1

0.6

0.7

13.78

9963

60454

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2369

11323

1.55

77.69

5.5

3.6

ng/l

129.0

88.1

42.34

2057

9563

(3044889) 12 lead EKG panel

16077

104295

1.30

77.38

6.0

3.6

—

(3006504) Eosinophils/100 leukocytes in Blood

10895

67217

1.29

77.22

6.7

6.1

2.9

0.18

10193

62170

(3018418) pH of Serum or Plasma

7719

45480

1.32

77.16

5.6

4.1

7.4

0.76

1546

8474

(3019069) Monocytes/100 leukocytes in Blood

10944

67610

1.29

76.49

7.0

6.4

9.0

8.9

2.16

10256

62754

(42870588) Differential panel, method unspecified - Blood

8493

50793

1.30

75.77

6.3

5.9

—

(21494755) Public health laboratory ask at order entry panel

634

9382

0.47

75.43

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6382

36816

1.33

73.18

2.9

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10477

64749

1.28

71.04

2.2

2.0

pmol/l

92.2

94.6

5.36

5770

33721

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20544

154804

0.72

70.49

14.3

10.8

u/l

28.8

26.4

9.75

19879

148298

(3013650) Neutrophils [#/volume] in Blood by Automated count

13057

82977

1.27

70.24

9.0

9.5

e9/l

4.8

4.2

115.69

11304

71647

(3022313) Gas panel - Capillary blood

1624

7264

1.65

69.88

5.0

3.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

20590

155057

0.72

69.68

30.8

17.4

umol/l

93.5

80.4

197.71

20583

154998

(3020630) Protein [Mass/volume] in Serum or Plasma

2713

13661

1.48

69.11

2.4

2.7

g/l

65.3

66.4

10.70

2460

12270

(3002030) Lymphocytes/100 leukocytes in Blood

11073

69085

1.27

68.62

6.8

6.2

24.1

26.9

123.86

10302

63702

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

125

136

6.62

67.86

8.1

6.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

6332

36807

1.32

67.74

1.7

1.5

nmol/l

18.8

20.5

10.51

5525

30822

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

638

2133

2.18

67.34

7.2

6.1

mg/l

12.2

11.7

1.88

591

1966

(3018010) Neutrophils/100 leukocytes in Blood

10900

67979

1.27

67.24

6.6

6.0

60.4

57.9

83.01

10190

63021

(3036489) Thrombin time

1197

5007

1.75

65.80

2.6

1.9

22.8

21.5

3.83

1101

4432

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

927

3586

1.89

65.66

3.1

2.3

222.8

198.9

11.26

885

3387

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3032

15741

1.44

65.60

4.7

3.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

860

3246

1.93

65.55

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

860

3248

1.93

65.43

1.4

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

17444

115554

1.28

62.73

9.1

7.8

u/l

82.8

79.8

10.87

16578

108165

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

752

9929

0.53

62.63

2.1

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

886

3438

1.88

62.15

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

988

3985

1.81

61.32

2.9

2.0

86.2

89.3

3.78

948

3717

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

855

3309

1.88

60.44

1.5

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

890

3491

1.86

60.37

2.7

2.1

g/l

126.2

129.8

3.54

686

2426

(3013512) EKG study

7726

46720

1.27

59.14

6.3

3.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

852

3331

1.87

58.37

2.4

2.8

umol/l

31.9

34.6

2.63

711

2802

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2649

13744

1.43

56.94

2.8

2.5

u/l

63.7

49.6

0.22

2259

11791

(3031040) Bacteria [#/volume] in Urine by Automated count

14820

96920

1.24

55.03

5.7

4.5

e6/l

1354.3

1405.9

0.04

262

1472

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1440

6676

1.58

53.16

2.0

1.9

—

(40768804) Tissue Pathology biopsy report

7176

60287

0.79

53.12

2.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

548

1913

2.08

51.86

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1338

6149

1.59

51.21

1.9

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1193

5348

1.63

50.53

2.7

3.5

mg/l

42.3

45.3

0.35

955

4372

(3034860) Kappa light chains.free [Mass/volume] in Serum

1192

5356

1.63

50.01

2.7

3.5

mg/l

115.6

59.8

0.60

952

4369

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1393

6516

1.57

49.41

1.5

u/ml

12.7

15.4

0.30

175

(3040151) Glucose [Moles/volume] in Capillary blood

480

1622

2.15

49.39

10.5

9.3

mmol/l

7.8

7.3

1.77

399

1341

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1160

5197

1.63

49.23

2.7

3.5

ratio

2.7

3.0

0.16

362

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1134

12654

0.63

49.19

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

612

2285

1.95

48.13

1.5

1.4

g/l

29.1

34.2

15.75

528

2065

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4704

27438

1.28

45.91

3.2

2.8

e6/l

1.2

0.18

2827

15531

(40760888) Immunoglobulin light chains.free panel - Serum

919

3945

1.70

45.89

2.7

3.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

582

2184

1.93

45.12

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

443

6225

0.50

44.66

1.6

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

225

556

2.92

44.51

12.2

2.9

mg/l

946.1

2816.0

0.79

171

378

(3004588) Protein electrophoresis panel - Serum or Plasma

2196

11495

1.41

44.29

2.2

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

653

2566

1.85

44.03

1.5

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

1026

4603

1.63

43.25

4.7

3.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

642

2531

1.84

42.85

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

18410

139021

0.81

42.07

24.2

14.1

ml/min/173m2

71.8

77.2

190.13

15872

114462

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4389

25668

1.28

41.37

3.4

3.0

e6/l

2.2

0.00

2560

13846

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

525

1960

1.94

41.34

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

450

1602

2.03

40.49

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2209

11783

1.38

39.64

3.6

2.7

ml/min/173m2

53.7

64.6

32.22

1036

4551

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

857

3770

1.65

39.02

1.5

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

205

523

2.83

38.40

36.8

33.2

ug/l

7.4

7.2

0.56

187

464

(40758558) Short blood count panel - Blood

6013

36718

1.23

38.34

7.0

7.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

238

659

2.61

38.22

1.8

2.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1314

6422

1.49

37.92

5.4

3.7

mmol/l

24.6

24.9

2.57

1214

5872

(3051651) Icteric interference index of Serum or Plasma

281

847

2.40

37.86

5.6

3.9

—

(3008037) Lactate [Moles/volume] in Venous blood

789

3431

1.67

37.54

4.7

2.9

mmol/l

1.7

1.6

1.02

769

3357

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

346

1146

2.18

37.52

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

500

1929

1.88

35.75

2.1

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

524

2057

1.85

35.50

1.5

e6/l

2596.7

3802.6

0.57

391

1489

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1062

5048

1.53

34.91

1.7

1.6

titre

238.0

273.3

0.18

200

(3042733) HLA Ab [Presence] in Serum

169

409

2.98

34.78

5.1

4.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2204

12020

1.35

34.12

2.2

2.4

nmol/l

372.9

376.3

0.25

2011

11023

(3017569) Oxygen content in Arterial blood

227

651

2.52

34.03

1.9

2.3

—

(3021589) Normoblasts [#/volume] in Blood

9799

63217

1.19

33.89

13.2

9.8

e9/l

0.0

1.14

7955

51473

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5315

32403

1.23

33.64

1.8

1.7

pmol/l

41640154.0

30452240.8

0.60

4330

26051

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2650

14875

1.31

33.57

2.1

2.3

g/l

0.2

6.16

2403

13772

(3019977) pH of Arterial blood

266

835

2.30

32.82

2.5

7.4

1.05

309

(3041354) Potassium [Moles/volume] in Venous blood

488

1921

1.84

32.80

3.3

2.2

mmol/l

4.2

4.1

5.22

482

1910

(3035285) Chloride [Moles/volume] in Venous blood

488

1921

1.84

32.80

3.3

2.2

mmol/l

105.4

0.01

482

1910

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

510

2038

1.81

32.67

1.5

—

(40761535) Cells panel - Urine sediment

2276

12560

1.33

32.46

4.1

3.4

—

(40761511) CBC panel - Blood by Automated count

19984

148791

0.81

31.96

25.0

13.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

480

1900

1.83

31.72

3.3

2.2

—

(1761868) Lipid panel - Serum or Plasma

5634

46606

0.83

30.84

4.1

3.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

289

4138

0.50

30.81

1.6

1.7

—

(3038515) Glucose [Moles/volume] in Venous blood

733

3293

1.62

30.73

5.0

2.9

mmol/l

8.2

7.6

4.24

716

3230

(3036782) Glucose [Moles/volume] in Pleural fluid

403

1524

1.91

30.67

1.4

mmol/l

7.0

6.1

7.56

369

1400

(44806118)

392

1475

1.92

30.28

1.5

—

(44790049)

392

1476

1.92

30.22

1.5

—

(44790047)

392

1476

1.92

30.22

1.5

—

(44790048)

392

1476

1.92

30.22

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

471

1885

1.81

30.06

1.5

e6/l

57289.5

61689.2

0.09

295

1128

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

663

2941

1.63

29.26

1.3

titre

84.3

159.2

0.98

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1143

5719

1.46

29.23

2.7

—

(3051611) Lipemic interference index of Serum or Plasma

416

1618

1.86

29.09

5.2

3.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

15064

101380

1.17

28.79

5.3

4.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2189

12213

1.31

28.75

1.8

1.5

—

(3012441) Differential panel - Pleural fluid

449

1798

1.81

28.62

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

899

4305

1.52

28.55

1.6

1.4

iu/ml

12.0

14.4

0.29

(3045788) Cell count panel - Pleural fluid

402

1560

1.86

28.32

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

947

4595

1.50

28.25

1.9

1.7

—

(3004775) Volume in Urine collected for unspecified duration

334

1225

1.97

27.83

2.4

2.1

688.5

682.0

0.09

226

787

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

393

1524

1.86

27.76

3.4

2.8

—

(3045716) Anion gap in Serum or Plasma

201

602

2.41

27.61

2.0

2.5

mmol/l

9.1

0.06

144

434

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

816

3879

1.53

26.83

3.6

2.8

mg/l

2.1

1.6

35.42

744

3515

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

398

1577

1.82

26.30

1.3

u/l

312.3

564.5

3.50

375

1488

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2227

12623

1.29

25.89

1.8

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

685

3168

1.57

25.48

1.2

—

(4094501)

767

3648

1.53

25.17

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

794

3819

1.51

24.73

1.6

1.5

g/l

1.2

0.75

752

3610

(3011397) Hemoglobin [Presence] in Urine by Test strip

5443

34082

1.19

24.68

4.2

3.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

770

3691

1.51

24.37

1.6

1.5

g/l

0.2

2.23

729

3471

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

548

2441

1.63

23.86

5.1

2.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.62

23.56

2.7

2.8

—

(3016750) Collection duration of Urine

243

854

2.05

22.87

2.2

2.0

min

495.7

493.9

0.09

172

602

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

508

2248

1.63

22.72

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

564

2569

1.59

22.43

1.2

1.3

u/l

33.5

39.0

0.61

495

2206

(3001019) Free T4 and TSH panel - Serum or Plasma

341

4215

0.57

22.23

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2297

13340

1.26

21.78

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1463

8013

1.33

21.74

1.8

2.0

g/l

1.2

1.4

3.53

1329

7214

(3035350) Ketones [Presence] in Urine by Test strip

10597

70300

1.14

21.66

4.5

3.6

estimate

0.0

0.75

2008

12477

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

210

713

2.12

21.65

2.2

2.1

ug/min

281.3

82.6

0.91

161

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1158

6127

1.37

21.56

2.2

2.4

g/l

10.0

10.3

1.64

969

5046

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

502

2246

1.62

21.51

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1224

6536

1.36

21.51

2.2

2.3

g/l

3.8

3.9

0.33

885

4613

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1227

6561

1.36

21.38

2.2

2.3

g/l

7.8

7.4

9.54

900

4837

(40768806) Pleura Pathology biopsy report

427

1838

1.68

21.27

1.5

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1224

6553

1.36

21.16

2.2

2.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1335

7243

1.34

21.15

3.2

3.3

pmol/l

4.2

4.4

9.45

1180

6364

(3020876) Protein [Mass/time] in 24 hour Urine

337

1360

1.79

21.08

1.9

g/24h

2.3

0.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

553

2555

1.57

20.73

1.6

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

971

1.93

20.71

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

310

1233

1.81

20.36

1.2

1.3

nmol/l

1.5

1.3

1.59

277

1118

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

730

3598

1.47

20.22

1.6

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

500

2279

1.59

19.88

1.6

1.4

u/ml

125.3

112.5

0.94

107

483

(21494890) Protein electrophoresis panel - 24 hour Urine

403

1745

1.67

19.68

1.6

2.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

177

2558

0.49

19.54

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

1407

7802

1.31

19.14

4.2

3.5

—

(3037756) Immunofixation for Serum or Plasma

733

3658

1.45

19.06

1.5

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

542

2542

1.54

19.05

1.6

1.4

u/ml

21.1

14.8

—

(3009261) Glucose [Presence] in Urine by Test strip

10688

71327

1.13

18.96

4.6

3.7

estimate

0.0

0.06

1876

12428

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

249

946

1.90

18.90

1.3

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

20842

153383

0.84

18.87

32.9

17.0

mmol/l

4.0

201.55

20483

149027

(3017181) Myelocytes/100 leukocytes in Blood

2135

12499

1.25

18.77

4.1

0.9

1.0

1.69

691

3924

(3019150) Specific gravity of Urine by Refractometry

4804

30357

1.17

18.70

5.1

4.1

kg/l

1.0

0.68

847

4612

(3027923) C peptide [Moles/volume] in Serum or Plasma

214

777

1.99

18.53

1.3

nmol/l

1.3

1.2

0.70

167

583

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

365

1567

1.68

18.44

1.2

u/l

54.7

62.5

1.37

237

1029

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1137

6166

1.34

18.07

2.2

2.4

g/l

3.2

3.1

4.73

893

4713

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

607

2952

1.49

18.02

6.2

5.3

iu/ml

2344.4

1104.5

0.40

108

465

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

919

4830

1.38

17.85

2.2

2.3

g/l

0.1

0.0

0.40

837

4376

(3017704) Immunofixation for Urine

236

899

1.89

17.81

1.3

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

437

1986

1.59

17.65

1.4

1.3

nmol/l

0.2

0.3

0.85

152

(3025941) Bacteria identified in Stool by Culture

1268

7009

1.31

17.65

1.3

—

(3014891) Appearance of Pleural fluid

195

3.02

17.63

1.7

1.6

—

(3022621) pH of Urine by Test strip

1681

9645

1.27

17.55

3.5

3.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

867

4534

1.39

17.37

2.2

2.4

g/l

0.0

0.40

787

4090

(3021601) Nitrite [Presence] in Urine by Test strip

10535

70497

1.13

17.27

6.0

4.9

estimate

0.0

1.08

2039

12746

(46235355) HIV 1 and 2 tests - Meaningful Use set

2449

14673

1.22

17.26

1.8

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

213

794

1.93

17.16

1.9

2.2

umol/l

22.8

33.6

0.60

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

19880

146660

0.86

17.15

7.0

4.9

mmol/l

2.1

2.8

307.65

18634

132258

(3005719) IgG [Mass/volume] in Serum or Plasma

1782

10326

1.26

17.11

2.6

2.9

g/l

10.5

10.7

0.76

1644

9378

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

851

4454

1.38

16.97

2.2

2.4

g/l

0.0

0.00

781

4075

(3009542) Hematocrit [Volume Fraction] of Blood

17144

127705

0.88

16.92

27.7

16.1

38.2

39.7

54.92

10582

85817

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.08

16.81

12.7

14.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

958

5120

1.36

16.78

2.1

2.3

g/l

36.2

37.5

8.79

821

4300

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

544

5679

0.68

16.76

3.4

4.0

u/ml

106.4

76.8

0.53

521

5446

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

405

1836

1.59

16.56

1.4

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

432

1992

1.57

16.44

1.4

1.3

nmol/l

3.1

1.6

0.26

414

1901

(3002179) Metamyelocytes/100 leukocytes in Blood

1923

11290

1.24

16.43

3.9

0.6

0.7

0.93

501

2831

(43055442) Apixaban [Mass/volume] in Serum or Plasma

200

2.91

16.37

1.7

1.4

ug/l

134.9

115.3

0.73

150

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1602

14217

0.80

16.33

2.1

2.2

nmol/l

11.9

13.0

6.40

1370

12571

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5217

41712

0.87

16.30

2.9

3.1

ug/l

0.8

0.25

3729

28255

(3035880) pH of Pleural fluid

235

921

1.84

16.29

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

222

859

1.86

16.03

1.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

20828

152990

0.86

16.02

32.6

16.9

mmol/l

139.3

139.7

54.07

20497

148861

(3021440) Promyelocytes/100 leukocytes in Blood

2005

11857

1.23

16.00

4.1

0.1

3.60

642

3646

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

221

856

1.86

15.91

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2112

12570

1.23

15.85

5.6

3.8

mmol/l

1.2

19.13

1913

10842

(3025159) Blasts/100 leukocytes in Blood

1875

11021

1.24

15.84

4.2

4.1

0.0

0.3

3.81

550

3058

(3025315) Body weight

112

3.59

15.74

6.0

4.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

101

287

2.53

15.72

1.2

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1022

5597

1.32

15.22

2.3

2.5

g/l

0.7

1.0

2.68

875

4691

(3003181) Sodium [Moles/volume] in Urine

578

2885

1.45

15.10

1.4

1.3

mmol/l

60.6

62.2

0.41

462

2279

(40768800) Prostate Pathology biopsy report

476

4985

0.68

14.95

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

157

3.07

14.83

1.3

1.2

nmol/l

8.4

253086.7

0.91

130

(3037522) Nuclear Ab [Titer] in Serum

2786

17147

1.19

14.62

1.3

titre

529.7

513.8

0.18

653

3618

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

642

3289

1.41

14.56

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5990

39029

1.13

14.53

1.8

1.6

mmol/l

1.4

1.62

5015

32100

(40768446) Kidney Pathology biopsy report

153

539

2.04

14.51

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

162

584

2.00

14.44

1.5

1.4

62.8

62.2

0.09

125

486

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

630

3224

1.41

14.39

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

679

3523

1.39

14.32

1.2

titre

834.0

923.4

0.17

101

(3052592) Norovirus Ag [Presence] in Stool

275

2.48

14.28

1.5

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

591

2996

1.43

14.23

2.0

1.6

nmol/l

0.9

0.8

2.60

483

2506

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.58

14.19

15.4

9.0

e6/l

144.0

188.9

0.29

(3014765) Yersinia sp identified in Stool by Organism specific culture

717

3761

1.38

14.17

1.2

—

(3042631) Mycobacterium sp identified in Specimen

479

2337

1.48

14.10

2.6

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

19386

142877

0.88

14.07

6.0

4.8

mmol/l

6.4

6.0

228.26

17706

128078

(42529406) Shigella sp [Presence] in Stool by Culture

717

3769

1.38

13.99

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

199

779

1.84

13.93

3.5

3.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

438

2105

1.50

13.88

1.3

1.2

u/ml

313.4

280.3

1.12

292

1309

(3011985) Renin [Units/volume] in Plasma

402

1897

1.53

13.88

1.3

1.4

mu/l

88.9

59.2

1.52

359

1679

(3007566) Smooth muscle Ab [Titer] in Serum

682

3561

1.39

13.87

1.2

titre

99.7

135.5

0.58

290

(3010375) cycloSPORINE [Mass/volume] in Blood

167

619

1.94

13.79

23.7

29.5

ug/l

109.1

116.2

0.61

119

534

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

709

6845

0.74

13.77

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

379

1769

1.55

13.76

1.3

1.2

u/ml

4.8

3.8

0.67

168

768

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.33

13.66

5.1

3.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

369

1715

1.55

13.65

1.4

1.3

nmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

708

3731

1.37

13.62

1.2

—

(3037121) Protein [Mass/volume] in Urine

985

5453

1.31

13.60

3.0

3.2

g/l

0.4

0.3

3.14

480

2467

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

450

2.10

13.32

3.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

450

2.10

13.32

3.0

2.3

—

(3051593) INR in Capillary blood by Coagulation assay

204

817

1.80

13.30

11.5

9.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

292

1292

1.63

13.29

1.3

u/l

12.5

14.1

0.46

257

1197

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

381

4061

0.67

13.16

2.4

1.6

mg/l

5.3

3.6

1.31

305

2914

(3044927) Protein electrophoresis panel - Urine

375

1768

1.53

13.04

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

627

3264

1.39

13.01

2.5

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

5809

38014

1.13

12.85

5.1

4.1

estimate

0.0

0.34

1843

12113

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

247

1060

1.68

12.67

1.3

1.4

—

(3012565) Volume of 24 hour Urine

181

712

1.83

12.53

2.1

2.2

1754.2

1969.9

1.95

151

624

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

456

2263

1.45

12.37

2.8

2.6

u/ml

681.1

7298.1

1.04

154

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

195

789

1.78

12.33

1.6

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

689

3676

1.36

12.30

1.9

mg/l

12.8

11.5

1.15

639

3389

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1421

8331

1.24

12.28

2.6

2.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

457

2275

1.45

12.21

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

240

1042

1.66

11.82

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1446

0.48

11.73

1.3

1.4

pmol/l

60.7

98.1

0.99

466

(3024932) HLA-DR beta [Type]

123

437

2.03

11.52

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

233

1019

1.65

11.19

1.2

1.1

mmol/l

36.3

33.8

0.82

196

852

(40762365) Oxygen content in Arterial blood by calculation

268

2.31

11.14

3.1

3.4

ml/dl

14.6

14.7

0.07

255

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.05

11.11

5.7

4.9

umol/l

424.7

432.8

0.07

(3000492) Spirometry study

2038

12494

1.19

11.10

1.5

—

(3003338) MCHC [Mass/volume]

15835

117557

0.91

11.06

33.7

19.2

g/l

330.9

332.7

105.12

15668

116696

(40768797) Stomach Pathology biopsy report

3180

20190

1.15

11.05

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

210

897

1.69

11.03

1.3

u/l

109.9

91.0

1.40

183

772

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

205

870

1.70

11.03

1.3

u/l

30.8

26.1

0.55

174

737

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

118

422

2.01

10.88

1.4

20.7

23.1

0.41

358

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1059

9410

0.80

10.87

2.4

au/ml

25.9

27.4

0.10

397

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

332

1593

1.50

10.73

1.4

1.8

—

(3024471) HLA-A [Type]

124

454

1.97

10.72

1.0

—

(3002256) Pathology report gross observation

2486

20405

0.86

10.69

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

315

1496

1.52

10.69

1.4

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

217

945

1.65

10.62

1.2

mmol/l

12.0

12.1

0.11

325

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

19518

136703

1.12

10.53

8.5

5.9

mmol/mol

43.8

40.0

307.65

18323

124208

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

289

2.21

10.51

2.8

2.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

603

3234

1.35

10.47

1.3

1.4

—

(40768793) Breast Pathology biopsy report

247

2740

0.64

10.47

1.2

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

949

8499

0.79

10.45

1.3

au/ml

51.3

52.8

0.06

388

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

437

2228

1.41

10.33

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

6.50

10.29

7.7

8.4

40.1

52.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4423

28815

1.12

10.23

5.2

4.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

363

1792

1.46

10.21

1.2

1.3

pmol/l

222.2

288.7

2.25

275

1368

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

214

939

1.64

10.20

1.6

1.5

u/l

5.9

6.3

0.13

436

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

6.20

9.89

8.2

8.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

263

1223

1.55

9.86

1.4

u/l

14.3

12.6

3.42

254

1172

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1355

8094

1.21

9.80

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

240

1096

1.58

9.74

1.2

titre

136.6

144.4

0.07

183

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

452

2344

1.39

9.72

1.7

1.9

ug/l

24.5

0.00

438

2296

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1014

5888

1.25

9.62

1.8

1.9

u/l

36.7

39.1

2.90

831

5122

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

239

1095

1.57

9.58

1.2

titre

88.6

147.9

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

241

2.27

9.53

1.6

1.4

11.6

11.8

0.02

126

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1418

8543

1.20

9.39

3.4

2.7

e6/l

0.4

0.3

0.83

1396

8373

(4035726)

1767

14730

0.85

9.25

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

162

679

1.72

9.21

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

545

2938

1.34

9.20

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

183

793

1.66

9.20

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

278

1330

1.51

9.19

1.3

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

278

1330

1.51

9.19

1.3

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

278

1330

1.51

9.19

1.3

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

363

1834

1.43

9.09

1.3

1.2

u/ml

2.8

4.3

1.23

132

635

(3035947) Staphylolysin Ab [Units/volume] in Serum

174

748

1.67

9.03

1.2

1.1

iu/ml

3.1

3.3

—

(40757373) Influenza virus identified in Isolate

287

2.10

8.83

1.5

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

511

4829

0.75

8.68

1.7

nmol/l

41.6

43.1

0.87

485

4673

(3006442) Creatine [Moles/volume] in Serum or Plasma

208

946

1.58

8.65

1.5

1.6

umol/l

73.3

72.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

153

643

1.71

8.65

2.4

2.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

196

883

1.60

8.49

1.4

umol/l

16.2

13.5

3.73

178

834

(4010399)

1728

10690

1.17

8.45

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

770

4400

1.26

8.44

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

181

803

1.62

8.36

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

181

803

1.62

8.36

1.3

1.5

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

117

460

1.83

8.30

1.5

1.3

22.0

21.3

0.11

417

(4268621)

245

1168

1.51

8.29

2.4

2.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

339

1.97

8.26

1.9

227.4

192.0

1.91

319

(3001893) Eosinophils/100 leukocytes in Pleural fluid

127

513

1.78

8.25

1.5

1.4

3.2

2.6

0.33

100

437

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

19537

143021

0.91

8.25

6.2

4.4

mmol/l

3.8

4.7

307.65

18371

129572

(3000570) Elastase.pancreatic [Mass/mass] in Stool

795

4575

1.26

8.22

1.4

ug/g

250.4

261.0

0.78

497

2718

(3000093) Morphology [Interpretation] in Blood Narrative

305

1523

1.44

8.19

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

152

648

1.69

8.18

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

404

2122

1.37

8.13

1.5

1.6

g/l

0.8

0.9

0.83

306

1564

(3000012) Reticulocyte production index

199

910

1.57

8.12

1.6

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

173

765

1.63

8.11

1.1

u/l

49.4

24.3

1.57

131

572

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

207

2247

0.66

8.03

1.6

1.5

pmol/l

258.1

204.7

0.43

202

2186

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

172

768

1.61

7.77

1.1

u/l

125.9

82.9

2.28

134

597

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

170

757

1.62

7.77

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

7657

51861

1.09

7.72

3.4

3.6

mmol/l

2.3

2.4

12.00

6555

44322

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

203

2.23

7.70

1.3

u/l

45.2

423.7

0.94

140

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

131

547

1.72

7.64

1.8

umol/l

79.7

108.3

1.08

280

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

250

1219

1.48

7.63

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

305

1.98

7.58

1.2

mmol/l

1.4

1.8

1.81

178

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

191

2.26

7.55

1.4

74.7

70.0

0.57

156

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

111

443

1.80

7.55

1.9

178.0

167.6

0.63

103

415

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

137

582

1.69

7.52

4.3

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

346

1797

1.39

7.49

1.3

1.4

—

(4306422)

339

1755

1.39

7.48

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

315

1612

1.41

7.44

3.2

3.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

209

989

1.52

7.38

2.8

2.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

134

570

1.69

7.33

1.4

1.3

mmol/l

3.4

3.6

0.23

119

527

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

140

2.46

7.32

1.4

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

199

2.20

7.27

2.4

2.3

mg/l

102.5

55.4

0.59

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7867

53456

1.08

7.21

5.0

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1930

15687

0.87

7.15

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

331

1721

1.39

7.15

1.2

1.1

110.1

116.7

2.54

299

1532

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

353

1.87

7.11

4.5

6.2

70.1

70.2

0.01

279

(3033923) Metanephrine [Moles/time] in 24 hour Urine

278

1.99

7.09

1.1

umol/24h

22.2

0.7

0.49

137

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

193

2066

0.67

7.04

3.2

3.6

u/ml

36.4

42.5

0.36

178

2011

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

545

1.69

7.00

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

740

4311

1.24

6.93

5.0

4.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

180

2.24

6.93

1.1

1.6

—

11.0

—

(3049717) Cytology report of Urine Cyto stain

1176

7170

1.19

6.89

2.7

2.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

370

1971

1.35

6.89

1.3

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

262

1321

1.43

6.77

1.2

1.1

90.8

96.7

3.15

251

1203

(3024522) Salmonella sp identified in Specimen by Organism specific culture

370

1980

1.35

6.70

1.3

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

503

2812

1.29

6.68

3.3

3.5

1.4

1.5

0.39

398

2155

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

300

1.92

6.65

1.2

—

(3045414) Leukocytes [Presence] in Urine

1077

6544

1.19

6.58

2.2

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

214

1046

1.47

6.52

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

105

433

1.74

6.47

1.3

g/l

16.8

12.1

6.08

326

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4374

29106

1.10

6.46

3.1

3.3

mmol/l

2.5

3.13

3713

25491

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

364

1957

1.34

6.41

1.3

1.5

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.13

6.36

1.1

1.2

ng/l

10083.1

2219.8

0.89

(3042010) Triglyceride [Moles/volume] in Pleural fluid

245

1.99

6.34

1.3

1.2

mmol/l

0.5

1.5

2.15

155

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

375

2029

1.33

6.34

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

364

1961

1.34

6.33

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

363

1956

1.34

6.31

1.3

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

967

0.55

6.26

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

189

2.13

6.20

5.2

4.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

521

1.66

6.16

2.0

1.8

e6/l

17428.6

9143.4

0.65

287

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

251

1287

1.40

5.97

2.0

2.1

u/field

2.5

0.00

504

(3004716) Salmonella sp identified in Stool by Organism specific culture

842

5065

1.20

5.80

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

384

1.74

5.76

1.4

1.3

g/l

28.5

43.5

0.45

289

(3014148) Varicella zoster virus Ab [Titer] in Serum

231

1176

1.41

5.74

1.1

—

(3008898) HLA-B27 [Presence]

333

3135

0.76

5.67

1.1

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

110

480

1.65

5.58

1.1

u/ml

1.6

14.8

1.47

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.61

5.56

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

170

1775

0.69

5.55

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

117

522

1.61

5.45

1.2

1.4

umol/l

7.2

15.7

2.88

372

(3011544) Albumin [Mass/volume] in Pleural fluid

157

2.15

5.39

1.1

g/l

14.7

18.0

2.13

138

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

386

2149

1.29

5.38

2.5

2.0

mg/l

21.2

28.2

2.10

105

555

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

324

1761

1.32

5.38

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

371

1.72

5.36

1.6

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

327

1782

1.32

5.34

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

282

1.83

5.33

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

400

1.69

5.27

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

593

5172

0.82

5.27

1.4

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

170

1756

0.69

5.26

1.6

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

19423

141613

0.93

5.24

6.1

4.4

mmol/l

1.3

1.5

307.65

18131

127450

(3023487) Leukocytes [#/volume] in Peritoneal fluid

130

601

1.56

5.24

2.0

1.9

e6/l

12172.1

1107.7

0.88

415

(3027135) IgG subclass 1 [Mass/volume] in Serum

251

1321

1.37

5.17

1.3

1.4

g/l

6.9

0.10

177

875

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.67

5.16

3.8

3.6

—

(3033799) Differential panel - Peritoneal fluid

117

530

1.59

5.15

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

170

836

1.46

5.13

2.1

1.9

u/field

2.2

2.3

0.08

117

588

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

653

3883

1.21

5.13

1.8

1.7

—

(4211845)

159

772

1.48

5.12

3.4

3.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

20312

143657

1.08

5.09

25.8

14.8

mg/l

26.9

26.4

1.34

17980

114583

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

215

1.94

5.08

1.4

1.2

84.6

0.00

(40768795) Lymph node Pathology biopsy report

155

1616

0.69

5.07

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

391

2200

1.28

5.05

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

685

0.52

5.05

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

223

1156

1.39

5.05

2.2

2.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

250

1321

1.36

5.04

1.3

1.4

g/l

0.4

0.45

180

878

(4062490)

250

1321

1.36

5.04

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

250

1323

1.36

4.99

1.3

1.4

g/l

2.8

3.0

0.76

178

876

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

8.97

4.89

1.1

1.3

—

(3014271) Vancomycin [Susceptibility]

198

1013

1.41

4.86

3.3

2.9

—

(3012898) Urea [Moles/volume] in Urine

145

2.13

4.86

1.5

1.3

mmol/l

124.7

171.2

2.19

123

(3020191) Ethanol [Moles/volume] in Serum or Plasma

218

1134

1.38

4.85

1.4

promille

1.2

1.4

0.79

164

885

(1002224) Polysomnography panel

579

5016

0.82

4.84

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

363

2037

1.28

4.81

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

215

1.90

4.77

1.4

1.1

75.0

77.1

0.14

(4146454)

350

1959

1.29

4.74

3.0

2.6

—

(3003129) Base excess in Capillary blood by calculation

429

1.63

4.74

1.6

1.8

mmol/l

0.3

0.6

0.30

406

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

134

1416

0.68

4.74

1.5

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8486

58469

1.06

4.74

2.4

2.2

nmol/l

76.0

79.0

16.82

7444

51320

(3006462) Nitrate [Presence] in Urine

147

715

1.48

4.73

3.5

3.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.72

4.73

1.1

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

332

1850

1.29

4.66

1.1

g/l

1.7

1.5

6.03

298

1664

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

216

1132

1.37

4.62

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2992

19864

1.09

4.59

12.1

6.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3502

23414

1.09

4.56

1.5

g/l

2.8

2.7

2.01

2043

13477

(3006270) Folate [Moles/volume] in Blood

238

1272

1.35

4.51

1.2

nmol/l

313.3

341.1

1.15

177

1051

(3042111) Morphology [Interpretation] in Bone marrow Narrative

477

2789

1.23

4.48

1.5

1.6

—

(3020491) Glucose [Moles/volume] in Blood

201

1049

1.38

4.43

2.2

1.9

mmol/l

7.5

7.1

0.99

147

704

(3016018) Differential panel - Cerebral spinal fluid

156

1575

0.71

4.32

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

392

1.61

4.23

1.5

2.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

110

517

1.53

4.21

3.1

2.1

ug/l

27.1

441.4

1.28

102

487

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

376

1.62

4.20

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

658

3997

1.19

4.18

1.6

e6/l

18141.2

15003.9

0.80

470

2878

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

268

1.74

4.16

1.1

1.2

mg/l

0.7

40.6

1.01

206

(3002621) Streptococcal DNAse B [Units/volume] in Serum

121

2.14

4.15

1.0

—

(3044007) Cell count panel - Peritoneal fluid

101

468

1.55

4.13

2.1

2.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

329

1.66

4.09

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

329

1.66

4.09

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

329

1.66

4.09

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

329

1.66

4.09

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

116

1221

0.68

4.08

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

186

1.89

4.08

4.9

4.6

ug/min

47.5

49.2

0.08

156

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

110

521

1.52

4.08

1.5

1.7

u/ml

121418.4

20124.4

0.38

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

854

0.62

4.04

5.3

6.7

—

(3044290) Cell count panel - Cerebral spinal fluid

325

2930

0.79

4.04

1.2

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

420

1.57

4.02

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

758

4677

1.17

4.01

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

105

1119

0.67

3.96

4.1

5.4

u/ml

44.5

92.9

1.49

335

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

545

4651

0.84

3.94

1.3

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

336

1920

1.26

3.93

3.5

3.9

—

(3034426) Prothrombin time (PT)

400

1.58

3.92

1.4

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.50

3.91

1.3

g/l

0.1

0.28

(40763791) Oxygen content in Venous blood by calculation

3.47

3.90

5.5

6.1

ml/dl

12.3

12.0

0.11

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

111

533

1.50

3.88

1.5

1.7

nmol/l

3.9

9.1

0.62

461

(3037692) Legionella sp identified in Specimen by Organism specific culture

117

570

1.48

3.82

1.2

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

238

1308

1.31

3.79

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

366

1.59

3.72

1.4

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

459

2734

1.21

3.67

1.2

u/ml

13.4

12.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

529

3193

1.19

3.67

1.3

u/ml

8.8

5.7

0.63

512

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

573

0.56

3.66

1.5

1.4

—

(40761536) Microorganisms panel - Urine sediment

1850

12145

1.10

3.65

5.2

4.0

—

(3025130) Human papilloma virus identified in Specimen

875

0.65

3.64

1.7

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

410

2422

1.22

3.58

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

260

1462

1.28

3.52

1.3

1.2

u/ml

53.9

54.8

0.02

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

562

3427

1.18

3.49

1.2

u/ml

60.1

38.7

0.87

190

(3047189) Immunofixation for 24 hour Urine

152

792

1.38

3.48

1.5

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

408

3528

0.83

3.46

1.8

1.9

pmol/l

192.7

201.9

1.19

386

3323

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

224

1.73

3.45

1.4

1.2

ng/l

72.6

519.7

0.67

151

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

121

2.02

3.44

1.6

2.1

mmol/l

0.4

1.1

1.91

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

693

5729

0.86

3.42

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

521

3163

1.19

3.42

1.3

u/ml

8.3

6.0

0.26

341

(3018851) Theophylline [Moles/volume] in Serum or Plasma

137

1.94

3.37

1.8

1.6

umol/l

54.3

42.2

1.15

137

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

360

2116

1.22

3.33

1.1

iu/ml

538.7

5539.6

0.47

427

(3044941) Cell count panel - Synovial fluid

422

2522

1.20

3.30

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

447

2686

1.20

3.30

1.2

u/ml

2.5

5.6

1.24

197

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

2119

1.22

3.29

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

453

0.54

3.28

2.1

2.4

nmol/l

122.4

147.5

0.77

388

(3015171) Extractable nuclear Ab [Units/volume] in Serum

751

4710

1.15

3.27

1.2

u/ml

1.0

0.06

408

(4281824)

158

1515

0.75

3.26

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

239

2170

0.79

3.25

1.3

1.4

iu/l

31.0

33.2

0.41

201

1831

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

636

3943

1.16

3.24

1.6

iu/ml

9.6

2.4

0.43

152

871

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2701

20716

0.93

3.24

5.8

4.6

33.2

31.9

7.00

2166

13166

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

312

1.59

3.22

1.2

1.1

77.7

85.2

0.95

156

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

162

865

1.35

3.22

1.3

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

147

773

1.37

3.22

1.2

u/l

304.3

384.7

0.37

142

718

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

318

1.58

3.20

1.3

1.2

93.0

101.4

0.83

297

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

105

521

1.45

3.19

1.3

ug/l

243.7

351.7

0.39

292

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

347

1.55

3.18

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

162

867

1.34

3.17

1.3

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

162

867

1.34

3.17

1.3

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

162

867

1.34

3.17

1.3

2.0

—

(3027008) Opiates [Presence] in Urine

222

2025

0.78

3.15

1.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

118

601

1.41

3.13

2.2

2.4

umol/l

61.0

56.0

0.80

498

(3028300) Cannabinoids [Presence] in Urine

223

2030

0.79

3.12

1.8

1.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

179

0.36

3.11

2.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

179

0.36

3.11

2.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

180

0.36

3.11

2.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

180

0.36

3.11

2.0

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

327

1.56

3.08

2.2

2.4

mmol/l

7.7

0.03

202

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

152

811

1.35

3.05

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

15271

107641

1.05

3.04

4.8

4.1

mm/h

16.4

13.1

92.06

14096

98362

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

152

812

1.35

3.03

1.1

—

(3027944) Amphetamines [Presence] in Urine

218

1982

0.79

3.03

1.8

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

223

1259

1.27

2.99

1.6

u/ml

22.7

25.8

0.39

268

(3011335) Digoxin [Mass/volume] in Serum or Plasma

123

1.93

2.99

1.8

2.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

307

1.57

2.98

1.2

71.1

84.9

1.74

157

(3000764) Benzodiazepines [Presence] in Urine

223

2011

0.79

2.90

1.8

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

538

3325

1.16

2.90

4.3

3.3

mg/l

29.8

28.6

0.28

366

2075

(44786800) Granulocytes/100 leukocytes in Body fluid

220

1.67

2.89

1.4

20.5

27.0

0.79

178

(3050129) First trimester maternal screen panel - Serum or Plasma

201

0.36

2.89

1.6

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

302

0.47

2.88

1.3

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

152

1436

0.76

2.87

1.1

—

25.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

191

1064

1.29

2.86

1.3

titre

132.2

513.9

2.33

(3035637) Corticotropin [Mass/volume] in Plasma

301

1769

1.22

2.85

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

176

971

1.30

2.84

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

161

878

1.32

2.82

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

234

1341

1.25

2.80

1.6

1.4

iu/ml

43.1

24.7

0.68

(4034850)

731

4632

1.14

2.79

15.9

9.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

163

1.76

2.78

1.3

1.1

u/l

17.5

20.0

0.39

109

(3019174) dRVVT (LA screen)

2.03

2.73

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

356

1.49

2.69

2.2

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

427

3584

0.85

2.67

1.3

mg/l

599.9

578.9

0.17

402

3406

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

179

1000

1.29

2.65

2.4

1.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

252

1468

1.23

2.63

1.4

1.3

—

42.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

199

1.66

2.61

3.1

3.2

umol/l

43.3

41.5

0.21

170

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

228

1.61

2.56

1.5

1.3

104.9

111.2

0.53

218

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

381

2320

1.18

2.52

1.2

u/ml

29.6

47.3

1.89

221

(3017354) Segmented neutrophils/100 leukocytes in Blood

298

1776

1.21

2.50

3.1

3.5

65.0

58.3

5.25

189

1140

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

788

0.70

2.49

1.1

1.4

nmol/l

0.2

0.02

551

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

398

1.44

2.49

1.3

1.4

pmol/l

17.8

15.9

0.55

327

(3016879) Cocaine [Presence] in Urine

214

1899

0.81

2.47

1.8

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

150

0.38

2.47

2.0

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

259

1.55

2.46

1.1

—

(3022689) Creatine [Moles/volume] in Urine

441

1.42

2.45

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

248

1456

1.22

2.43

3.4

3.0

mg/l

98.5

44.1

1.19

183

1059

(3002523) Influenza virus A Ag [Presence] in Specimen

153

1408

0.78

2.43

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

183

1041

1.26

2.39

1.3

titre

170.8

63.1

0.50

(3003740) Influenza virus B Ag [Presence] in Specimen

154

1411

0.78

2.37

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

172

1.67

2.36

5.0

2.6

mg/l

1.5

1.1

0.83

127

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

108

1.86

2.35

2.9

5.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

181

0.40

2.35

1.8

1.5

—

(3005033) Fetal Nuchal fold Thickness US

147

0.39

2.34

2.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

148

0.39

2.34

2.0

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.26

2.33

1.1

nmol/l

250.8

263.4

0.16

(3046861) Legionella sp Ag [Presence] in Urine

1.96

2.33

1.2

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

1082

7098

1.10

2.28

1.4

1.3

u/ml

279.3

283.8

0.04

993

6528

(3050794) Legionella sp Ab [Presence] in Serum

125

1.78

2.28

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

136

1.74

2.26

1.2

1.1

umol/24h

12.8

1.7

0.50

136

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

518

0.65

2.26

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

154

1401

0.79

2.25

1.5

—

(3002619) Bacteria identified in Specimen by Culture

318

1.47

2.23

1.3

—

(3008295) Osmolality of Serum or Plasma

263

1569

1.21

2.23

1.4

1.3

mosm/kgh2o

276.3

277.2

0.24

207

1197

(3035611) Eosinophils/100 leukocytes in Synovial fluid

105

1.85

2.23

1.5

1.7

1.4

0.8

0.32

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

122

0.35

2.19

1.2

1.0

—

(3017732) Neutrophils [#/volume] in Blood

1308

10148

0.92

2.18

3.5

3.0

e9/l

4.7

4.1

9.62

936

7395

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

141

788

1.29

2.16

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

141

789

1.28

2.14

1.3

1.5

—

(3036603) Volume of Urine

182

1051

1.24

2.13

1.6

1687.1

1975.4

1.43

247

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

1.56

2.12

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

141

790

1.28

2.12

1.8

1.5

u/l

9.4

5.7

1.60

122

654

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

206

1.57

2.11

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7686

56640

0.96

2.06

4.3

23.0

21.5

12.35

3743

28456

(3001729) Color of Synovial fluid

124

1.74

2.06

1.4

1.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

170

0.42

2.06

1.0

1.2

u/ml

48.8

68.2

—

164

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

366

1.41

2.05

1.2

1.3

113.2

113.5

0.03

323

(3020650) Glucose [Presence] in Urine

348

0.60

2.05

1.3

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.90

2.01

1.5

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.90

2.01

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

147

1.66

2.00

2.1

62.3

59.2

0.17

(1001926) Buprenorphine [Presence] in Urine by Screen method

176

1553

0.81

2.00

1.9

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.93

2.00

1.5

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

373

3083

0.87

2.00

1.3

1.5

e6/l

499.4

2070.9

1.45

323

2498

(3035082) Kappa light chains [Mass/volume] in Urine

2.28

1.99

1.0

1.1

g/l

0.1

0.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.33

1.93

1.0

1.1

g/l

0.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

260

1574

1.19

1.93

1.4

1.3

e6/l

180358.3

119530.8

0.59

183

1075

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

383

1.39

1.93

1.2

1.3

g/l

0.3

0.50

313

(44816559) Phosphatidylethanol [Mass/volume] in Blood

361

2245

1.16

1.92

1.3

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

374

3077

0.87

1.90

1.3

1.4

e6/l

17.2

33.0

1.16

308

2365

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

133

1.67

1.89

1.1

iu/ml

14.0

14.1

0.00

(3024263) Appearance of Synovial fluid

150

861

1.25

1.89

1.6

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

170

990

1.23

1.89

1.0

1.1

mg/l

296.0

283.1

1.29

155

881

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

117

1.72

1.88

1.9

2.1

12.9

16.7

0.33

(3032743) Legionella sp IgG Ab [Presence] in Serum

101

1.78

1.87

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.09

1.87

1.0

pmol/l

124.9

187.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

145

1.63

1.85

1.2

ug/l

74.2

121.5

2.27

(3041096) Erythrocytes [Presence] in Urine by Automated

5268

36611

1.04

1.84

4.4

3.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

118

1.70

1.83

1.1

1.2

pmol/l

11.4

18.0

0.65

100

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

693

1.28

1.82

1.4

2.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.49

1.82

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

694

1.27

1.80

1.4

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

110

612

1.29

1.80

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

160

0.45

1.80

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

562

1.30

1.79

2.6

2.9

umol/l

30.7

28.9

0.68

427

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

1158

0.80

1.76

1.1

1.0

u/ml

2.6

1.7

0.37

254

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

124

703

1.27

1.76

1.4

2.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

175

1521

0.82

1.76

1.1

u/ml

3.8

1.1

0.87

591

(3044009) aPTT.lupus sensitive (LA screen)

1.76

1.75

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

473

3019

1.13

1.75

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

115

647

1.28

1.74

1.1

ratio

1.1

1.23

221

(21494567) Legionella sp IgM Ab [Presence] in Serum

104

1.73

1.72

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

857

0.77

1.71

1.4

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

473

1.32

1.70

1.6

1.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.84

1.69

2.8

1.3

mmol/l

25.2

23.1

0.63

(44806420)

486

1.32

1.69

2.1

2.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

386

3139

0.88

1.68

1.2

1.3

mmol/l

4.2

3.8

6.43

363

2958

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

559

0.72

1.68

1.1

1.2

—

(3018133) Calcium [Moles/volume] in Urine

167

1.55

1.65

1.3

1.6

mmol/l

2.7

0.00

146

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

648

0.74

1.65

1.1

u/l

1.2

1.1

0.46

349

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

811

0.77

1.64

1.0

u/ml

2.1

0.5

0.46

200

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

247

0.58

1.64

2.2

1.8

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.77

1.59

1.1

1.2

nmol/l

0.1

0.08

(4015189)

498

1.30

1.58

2.4

2.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

198

0.54

1.56

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

559

0.73

1.55

1.0

1.1

u/ml

3.9

5.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

424

0.69

1.53

1.1

1.0

u/ml

0.5

0.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

158

1362

0.83

1.50

1.1

u/ml

6.6

4.3

0.38

518

(3021387) Prolactin [Units/volume] in Serum or Plasma

297

2432

0.87

1.48

1.6

1.8

mu/l

300.2

279.3

0.53

273

2260

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

496

0.72

1.48

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

138

1.56

1.46

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

167

1.50

1.45

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

473

1.29

1.45

1.1

96.5

99.9

0.41

378

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.87

1.45

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

418

0.70

1.43

2.1

1.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.31

1.41

1.1

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.85

1.41

10.8

8.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

173

1468

0.84

1.40

1.3

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

111

982

0.81

1.40

1.1

1.0

u/ml

5.4

3.1

0.67

368

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

331

0.67

1.39

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

140

1210

0.83

1.39

1.0

ng/l

43.1

42.9

0.02

836

(3023430) Cat dander IgE Ab [Units/volume] in Serum

104

926

0.81

1.39

1.1

1.0

u/ml

1.4

2.6

1.28

351

(3020618) Glucose [Moles/volume] in Synovial fluid

1.93

1.38

1.1

1.0

mmol/l

7.3

5.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

106

1.63

1.38

1.1

1.0

u/l

10.8

12.2

0.13

106

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

1.38

0.0

5.8

—

0.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

140

1208

0.83

1.37

1.0

ng/l

738.5

719.1

0.18

814

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

1.37

0.0

1.4

—

390.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

290

1.36

1.37

1.8

3.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

813

1.21

1.36

3.6

3.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

492

1.27

1.33

1.2

g/l

0.0

0.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

102

905

0.81

1.33

1.1

mg/l

44.8

47.8

0.28

769

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

14697

104294

1.03

1.33

4.1

3.8

pmol/l

15.1

15.0

3.93

13265

92704

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.99

1.32

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

493

1.27

1.32

1.4

1.3

70.2

55.5

4.02

419

(40758292) HTLV I+II Ab panel - Serum

249

0.63

1.32

1.1

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.00

1.31

1.2

1.1

mmol/l

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.39

1.30

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

861

0.81

1.28

1.1

mg/l

343.0

330.4

0.17

767

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

158

0.54

1.28

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

289

1.34

1.25

1.7

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

141

1202

0.84

1.24

1.0

ng/l

313.2

334.8

0.42

845

(3001964) Herpes simplex virus Ag [Presence] in Specimen

423

1.27

1.20

1.4

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17916

129584

0.97

1.20

5.1

4.5

mu/l

2.1

0.45

16308

115980

(3036670) Protein [Mass/volume] in Synovial fluid

532

1.24

1.20

1.1

1.3

g/l

39.6

40.7

0.32

283

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

475

1.25

1.19

1.2

—

(3000494) Fungus identified in Specimen by Culture

2557

17682

1.04

1.18

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

893

6836

0.94

1.17

1.2

iu/ml

129.5

133.2

0.09

298

2376

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.13

1.17

1.1

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

170

1.44

1.17

1.7

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

292

0.69

1.16

3.5

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

131

789

1.19

1.16

1.7

2.0

u/l

2730.0

1135.1

0.26

249

(3010370) Gastrin [Moles/volume] in Serum or Plasma

219

1.38

1.15

1.7

1.6

pmol/l

77.9

47.4

0.71

181

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2462

18336

0.96

1.15

3.4

4.3

ug/l

13.6

26.6

2.83

2038

15294

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

181

1122

1.16

1.14

1.2

u/ml

16.0

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

653

4348

1.08

1.13

1.5

—

(21494434) Karyotype in Bone marrow

236

1492

1.14

1.13

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

496

0.77

1.12

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

365

0.73

1.12

1.1

1.0

u/ml

0.6

0.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

148

1.46

1.11

1.4

—

416.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

829

0.82

1.11

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.28

1.10

5.4

3.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

437

0.76

1.09

1.1

1.0

u/ml

0.5

1.0

0.97

122

(3032352) Blasts [#/volume] in Cerebral spinal fluid

185

0.62

1.09

1.1

1.8

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

131

0.55

1.08

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.48

1.07

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

163

1349

0.87

1.04

1.0

u/ml

2.5

2.7

0.09

627

(3008401) Mugwort IgE Ab [Units/volume] in Serum

157

1301

0.87

1.02

1.1

1.0

u/ml

1.4

1.1

0.19

521

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

608

0.80

1.02

1.0

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

172

1074

1.15

1.01

3.3

3.8

nmol/l

116.1

151.0

1.09

172

1056

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

116

703

1.19

1.00

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

238

1.33

0.99

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

282

1.30

0.99

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

202

1.35

0.97

3.4

2.8

u/field

0.3

0.6

1.22

202

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

126

0.57

0.97

1.2

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

252

1.31

0.96

1.1

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

448

2963

1.09

0.96

1.5

1.7

iu/l

26.6

8.0

0.37

134

931

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.49

0.95

1.0

1.3

1.2

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

154

1269

0.87

0.95

1.9

2.2

46.6

37.6

1.68

155

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

130

1.44

0.93

1.3

ml/s/173m2

0.8

1.0

0.30

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3718

26020

1.03

0.91

1.3

1.2

u/ml

1.7

2.0

0.65

867

6352

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.84

0.90

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

152

1246

0.87

0.89

4.6

3.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

429

0.79

0.87

1.3

nmol/l

135.9

130.8

0.09

303

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

186

1183

1.13

0.87

1.2

u/ml

59.0

39.5

0.44

(40762887) Creatinine [Moles/volume] in Blood

1.85

0.87

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

396

0.78

0.86

1.1

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

309

2024

1.10

0.85

1.4

1.5

67.4

59.6

3.17

207

1289

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

284

1853

1.10

0.85

1.2

miu/ml

167.4

211.9

0.60

642

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.52

0.84

1.0

—

(3000285) Sodium [Moles/volume] in Blood

201

1.32

0.84

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

185

1180

1.13

0.84

1.2

u/ml

92.3

88.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

374

1.23

0.83

2.2

2.5

—

(3048689) Calprotectin [Mass/mass] in Stool

2074

14403

1.04

0.83

2.1

2.2

ug/g

193.4

158.6

2.58

1641

11188

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

172

0.67

0.83

6.6

5.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

226

1460

1.11

0.83

1.2

1.1

iu/ml

2.6

2.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

100

611

1.18

0.82

1.2

1.6

ug/l

12.8

8.3

0.57

558

(40765096) Chromosome analysis panel by Banding

528

0.82

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

221

1.30

0.82

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

551

0.82

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

196

1.32

0.82

2.3

2.1

—

(3038026) Centromere Ab [Units/volume] in Serum

189

1212

1.12

0.80

1.2

u/ml

57.2

50.5

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.79

0.0

1.1

—

0.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

138

1127

0.88

0.79

1.2

1.3

mmol/l

2.3

2.2

0.53

125

1055

(3024869) Neuronal Ab [Presence] in Serum

317

0.77

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

150

1216

0.88

0.77

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

211

1.29

0.76

1.9

2.1

—

(36660697) Celiac disease serology panel - Serum

1395

9637

1.04

0.76

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

180

1.32

0.75

1.1

1.3

mmol/l

6.0

6.8

0.42

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

386

1.21

0.75

1.4

1.6

ug/l

10.2

9.3

0.84

386

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

193

1.30

0.74

2.3

2.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.71

0.74

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

400

1.20

0.73

1.4

1.3

27.9

35.6

1.09

266

(3009214) Lutropin [Units/volume] in Serum or Plasma

367

2836

0.93

0.73

1.3

1.4

u/l

10.6

9.2

1.06

283

2273

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

100

828

0.87

0.72

3.8

5.7

u/ml

53.6

5056.6

0.65

156

(40768443) Skin Pathology biopsy report

940

7056

0.95

0.71

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

408

0.81

0.71

1.1

—

(3022145) Colonoscopy Study observation

2319

17101

0.97

0.70

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

114

1.39

0.69

1.3

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

721

4918

1.05

0.69

1.1

u/ml

19.8

11.4

0.17

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.59

0.69

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

177

1145

1.11

0.67

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

524

1.16

0.67

1.3

1.5

umol/l

13.6

25.7

6.64

499

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

306

2033

1.08

0.66

1.7

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.57

0.66

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

140

1.33

0.66

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

107

875

0.88

0.66

1.7

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

320

1.21

0.66

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.41

0.65

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

419

1.18

0.65

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

308

1.21

0.64

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.54

0.62

1.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2089

15395

0.97

0.62

1.8

1.7

1.6

6.32

1744

13234

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

641

0.86

0.62

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.62

0.0

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.55

0.60

1.6

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

119

760

1.12

0.59

1.4

1.3

g/l

1.5

0.08

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.62

0.59

4.0

3.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

264

0.79

0.59

1.4

1.5

ug/l

3.1

2.5

0.30

148

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.51

0.58

1.0

1.7

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.48

0.58

1.5

u/l

0.0

0.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

295

0.80

0.58

2.7

5.0

u/l

37.2

54.2

0.88

100

(3032868) Hemoglobin electrophoresis panel in Blood

108

0.66

0.57

1.4

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

125

1.32

0.57

1.3

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

574

0.86

0.57

1.3

1.5

umol/l

26.8

29.4

1.26

554

(40761539) Cells [Type] in Urine sediment by Light microscopy

426

1.16

0.56

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.66

0.56

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.66

0.56

1.3

1.4

mmol/24h

2.1

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

147

954

1.11

0.56

1.8

2.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

141

0.71

0.56

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19102

136538

1.02

0.55

5.5

4.0

mmol/l

1.4

1.3

24.95

17743

121685

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.63

0.55

1.6

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1185

8790

0.97

0.55

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

448

1.15

0.54

1.1

miu/ml

1719.6

1514.6

0.77

448

(3045424) Erythrocytes [Presence] in Urine

342

2610

0.94

0.53

1.6

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

631

0.88

0.53

1.1

ng/l

389.7

381.3

0.01

163

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.60

0.53

1.5

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.54

0.52

1.2

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

349

1.17

0.52

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

263

1759

1.07

0.52

1.3

—

(3028433) Virus identified in Specimen by Culture

530

1.14

0.52

1.1

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

337

0.83

0.51

2.1

1.8

mg/l

7.5

9.0

0.92

266

(3003327) Ova and parasites identified in Stool by Light microscopy

565

3872

1.05

0.51

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

234

0.80

0.50

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

291

1.18

0.50

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

109

1.32

0.50

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

178

0.77

0.50

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

138

901

1.10

0.49

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.63

0.49

8.0

6.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10109

73140

0.99

0.49

2.5

2.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

138

902

1.10

0.48

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

138

903

1.10

0.48

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.50

0.48

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

115

912

0.90

0.48

1.4

2.1

nmol/l

15.9

16.1

0.12

103

840

(3034891) Synovial lining cells/100 cells in Synovial fluid

731

0.89

0.47

1.4

1.5

2.5

4.1

0.85

160

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

136

0.74

0.47

1.1

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.36

0.46

1.9

1.3

u/field

1.0

1.1

—

(4027681)

631

0.89

0.46

1.3

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.32

0.46

2.5

2.9

pmol/l

20.6

61.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

363

0.85

0.45

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

281

1.18

0.45

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

138

906

1.09

0.45

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

167

0.77

0.45

2.2

2.1

umol/l

14.5

17.9

1.06

167

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

138

907

1.09

0.45

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

138

907

1.09

0.45

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

362

0.85

0.44

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

198

0.80

0.44

1.6

2.0

ug/l

1.3

9.9

1.31

100

(3026470) Cobalt [Mass/volume] in Blood

154

1198

0.92

0.44

1.9

2.0

ug/l

5.0

3.5

0.76

135

1051

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

232

1560

1.07

0.43

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

101

0.71

0.43

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

370

1.14

0.43

1.2

pmol/l

388.4

277.6

0.43

268

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.44

0.43

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.31

0.43

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

164

1.23

0.43

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

164

1.23

0.43

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

164

1.23

0.43

1.0

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

267

0.83

0.42

1.6

1.5

au/ml

30.0

61.8

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.42

0.0

1.8

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.42

0.0

1.9

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.41

0.0

1.6

—

14.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

130

857

1.09

0.41

1.5

1.3

u/ml

2.0

1.4

0.34

463

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

110

865

0.91

0.41

1.2

1.4

u/l

38.2

29.6

1.57

685

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

116

0.74

0.40

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

144

1118

0.92

0.40

1.9

2.6

e6/l

505.4

603.8

1.24

458

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.1

—

133.5

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

225

1518

1.06

0.39

1.2

mmol/l

8.1

7.6

1.19

156

1083

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

856

6333

0.97

0.39

2.9

3.6

u/ml

1553.7

1309.2

0.14

706

5484

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

140

1.23

0.39

1.2

1.3

mmol/l

10.9

10.0

0.43

(3039744) RNA polymerase III Ab [Units/volume] in Serum

114

1.26

0.39

1.1

1.0

—

5.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

202

0.82

0.38

1.1

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

222

1499

1.06

0.38

1.4

1.5

20.5

30.4

4.57

142

928

(3030313) Adrenal Ab [Titer] in Serum

1.39

0.38

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

517

3855

0.96

0.37

2.8

3.5

u/ml

1276.7

579.9

0.68

465

3502

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

100

655

1.10

0.37

1.0

1.1

iu/ml

11.1

11.0

0.01

144

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

181

1.19

0.36

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.39

0.35

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

5250

38057

0.99

0.35

1.3

—

(4133840)

391

0.88

0.35

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

337

0.87

0.34

1.3

1.2

mu/l

137.8

57.4

1.24

244

(3007733) Chloride [Moles/volume] in Urine

1.35

0.34

1.2

mmol/l

88.0

77.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

344

1.13

0.34

1.2

2.3

—

(4212803)

167

0.82

0.33

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

112

743

1.08

0.33

1.2

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

104

1.24

0.32

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

237

1.15

0.32

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

174

0.82

0.32

2.1

2.6

mmol/l

8.1

7.2

0.95

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

335

0.88

0.32

1.1

1.2

umol/l

1.7

3.0

5.78

307

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

142

953

1.07

0.32

1.6

2.6

e6/l

444.5

539.0

1.49

109

812

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.30

0.31

1.0

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

395

0.89

0.31

1.6

1.5

ug/l

0.4

0.03

245

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

836

0.93

0.31

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

304

2088

1.05

0.31

4.4

4.7

umol/l

344.8

351.5

0.36

257

1753

(3020961) Endomysium IgA Ab [Titer] in Serum

686

5065

0.97

0.31

1.1

titre

301.9

213.4

0.31

141

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

219

1655

0.95

0.31

1.1

au/ml

20.7

12.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

416

1.10

0.30

1.7

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

197

1341

1.05

0.29

1.2

—

(44806071)

164

0.83

0.29

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

148

0.82

0.28

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

414

0.90

0.28

1.1

1.3

23.3

21.8

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

193

1.15

0.28

1.1

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.77

0.28

1.2

1.3

umol/24h

240.3

374.0

—

(3002385) Erythrocyte distribution width [Ratio]

16093

115863

0.99

0.28

30.8

18.2

14.2

13.8

164.61

15810

113210

(4198724)

309

1.12

0.27

1.5

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

398

0.90

0.27

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

100

1.22

0.27

1.2

1.5

47.7

38.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

428

2972

1.03

0.27

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

228

1.13

0.26

1.4

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

139

0.83

0.26

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

820

0.94

0.26

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

123

0.82

0.25

1.1

u/ml

0.0

0.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

189

1293

1.05

0.25

1.8

1.9

mg/l

5.0

3.9

2.57

176

1237

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

403

0.91

0.25

1.2

1.1

—

(3048879) Bone marrow aspiration report

581

0.93

0.24

1.2

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

145

0.84

0.24

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

486

3584

0.97

0.23

1.8

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.76

0.23

1.0

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

258

0.89

0.23

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.74

0.22

1.3

1.5

—

(3036180) Methadone [Presence] in Urine

0.00

0.22

0.0

2.0

—

(3047185) IgG [Mass/volume] in Urine

1.20

0.21

1.0

1.1

—

42.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

446

1.08

0.21

1.7

2.1

12.9

10.8

0.37

402

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

591

0.93

0.21

1.7

2.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

579

1.07

0.21

1.2

mmol/l

6.1

6.2

0.50

551

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.21

0.0

1.4

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

199

1486

0.96

0.20

1.3

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

454

1.08

0.20

1.7

2.0

31.0

30.5

0.07

420

(3042517) Benzodiazepines panel - Urine

1.26

0.20

2.1

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

489

1.07

0.20

1.8

2.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.80

0.20

1.2

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

240

1.11

0.20

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.23

0.20

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

104

0.83

0.20

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

104

0.83

0.20

2.6

2.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.23

0.19

1.5

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.16

0.19

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

618

0.94

0.19

1.1

1.3

57.6

61.1

—

(3019225) pH of Specimen

2345

16992

0.99

0.18

5.8

4.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.23

0.18

1.1

1.3

nmol/l

431.4

607.9

—

(40762814) Titanium [Mass/volume] in Blood

358

0.92

0.18

2.1

2.3

ug/l

3.2

3.7

0.50

126

(3025577) Chromium [Mass/volume] in Blood

155

1159

0.96

0.18

2.0

2.1

ug/l

2.8

2.2

0.46

127

963

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12783

91474

1.01

0.18

3.7

3.1

u/l

66.3

55.1

20.03

11765

83819

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

430

3014

1.02

0.18

1.1

u/ml

15.6

8.9

0.34

284

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.83

0.18

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.17

0.18

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.17

0.18

1.3

—

(3011412) CD3 cells [#/volume] in Blood

198

1372

1.04

0.17

1.8

2.5

e9/l

1.0

1.1

0.59

111

804

(3028679) Herpes simplex virus Ab [Presence] in Serum

528

1.06

0.17

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

125

0.86

0.17

1.1

1.0

ug/l

96.2

85.9

—

(3016330) Potassium [Moles/time] in 24 hour Urine

200

0.90

0.17

1.4

1.2

—

85.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

200

0.90

0.17

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

230

1600

1.03

0.17

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.17

0.16

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

192

0.90

0.16

1.7

3.2

ng/l

38.4

156.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.22

0.16

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

116

797

1.04

0.16

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

115

790

1.04

0.16

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

444

3121

1.02

0.16

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

251

1.09

0.16

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

281

1964

1.03

0.15

3.3

3.5

nmol/l

7.9

9.3

0.18

273

1918

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.18

0.15

1.5

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

398

0.94

0.15

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

176

1.10

0.14

19.1

9.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.84

0.14

2.9

2.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.83

0.14

1.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

485

0.95

0.14

1.7

3.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.20

0.14

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.15

0.14

5.5

4.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

676

1.04

0.12

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

181

0.91

0.12

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

123

913

0.97

0.12

2.2

2.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

143

0.90

0.11

1.6

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

193

1.08

0.11

1.6

2.6

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.86

0.11

1.0

1.1

u/l

—

3.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.16

0.10

1.0

2.6

2.8

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.09

0.09

1.0

1.1

—

(44813793)

111

773

1.03

0.09

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.89

0.09

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

398

0.96

0.09

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

300

1.05

0.09

3.3

3.1

mg/l

6.4

7.7

0.77

241

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

463

0.96

0.09

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

0.91

0.08

1.3

1.1

—

(3013762) Body weight Measured

0.78

0.08

1.0

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

273

1.05

0.08

2.8

2.5

au/ml

86.3

139.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

513

3722

0.99

0.08

1.3

—

(40768441) Liver Pathology biopsy report

153

1121

0.98

0.07

1.2

1.3

—

(3013466) aPTT in Blood by Coagulation assay

1.08

0.07

1.1

1.2

37.6

38.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.06

0.07

1.4

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3042

21913

1.00

0.07

1.3

iu/ml

50.7

41.5

1.25

911

6769

(3010503) CD19 cells [#/volume] in Blood

134

941

1.02

0.07

1.8

2.6

e9/l

0.1

0.4

2.53

125

911

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9854

70837

1.00

0.07

4.8

5.1

ug/l

3.2

3.5

0.30

8707

63800

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

395

0.96

0.07

1.2

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

148

1041

1.02

0.07

1.8

2.0

72.6

71.0

0.68

133

991

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

211

1.05

0.07

1.3

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.91

0.06

1.1

u/ml

0.3

0.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

124

0.93

0.06

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

140

1022

0.98

0.05

1.7

2.0

14.0

15.4

0.46

406

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

234

1.04

0.05

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

110

804

0.98

0.05

1.0

1.1

nmol/l

5.8

6.4

0.06

173

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.08

0.04

1.2

1.6

11.3

13.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2847

20401

1.00

0.03

1.3

1.2

u/ml

16.8

14.9

0.52

947

7140

(3047007) Chlamydophila sp Ab [Presence] in Serum

219

1560

1.01

0.02

1.2

—

(4024509)

219

1560

1.01

0.02

1.8

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

222

0.97

0.02

1.2

1.3

43.7

54.9

0.47

(43055514) Macroprolactin [Presence] in Serum or Plasma

152

1.04

0.02

1.3

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

214

0.97

0.02

1.1

u/ml

0.8

0.9

0.11

103

(3051101) Glucose [Moles/volume] in Cord blood

317

1.02

0.01

5.6

6.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

539

1.01

0.01

2.6

3.2

mu/l

27.6

24.0

0.24

502

(3045142) Bone marrow Pathology biopsy report

271

1953

1.00

0.01

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

235

0.98

0.01

1.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

311

2239

1.00

0.01

2.3

2.6

u/ml

496.7

1323.7

0.83

303

2208

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

120

867

0.99

0.01

2.5

2.8

35.1

36.8

0.38

263

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.94

0.00

1.2

1.4

0.8

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

498

1.01

0.00

1.6

1.4

iu/ml

1647046.7

1612637.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

127

907

1.00

0.00

1.7

2.7

e9/l

0.2

1.39

108

802

(3038177) Helicobacter pylori Ab [Presence] in Serum

262

1876

1.00

0.00

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

369

1.01

0.00

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

162

0.97

0.00

1.8

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.96

0.00

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.97

0.00

1.5

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.97

0.00

1.7

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

166

0.99

0.00

2.7

2.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

189

0.99

0.00

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

181

0.99

0.00

1.4

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

586

1.00

0.00

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

196

0.99

0.00

1.6

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

162

1.02

0.00

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

125

0.98

0.00

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.00

0.00

1.0

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

186

1.00

0.00

1.2

1.1

—

(3016228) CD19 cells/100 cells in Blood

606

0.99

0.00

1.8

2.0

6.2

8.5

1.57

590

(3000060) B lymphocytes [#/volume] in Blood

311

0.99

0.00

1.7

2.0

e6/l

625.7

1609.4

0.50

163

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.00

0.00

1.3

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.01

0.00

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40758358) Immune stain study

0.90

0.00

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.97

0.00

1.0

1.1

mg/l

0.0

0.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.92

0.00

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_MI – Myocardial infarction

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Myocardial infarction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Myocardial infarction (I9_MI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints